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Abstract:
The recognition of DNA base mismatches is of considerable interest for both the 
diagnosis and treatment of mismatch repair-deficient cancers.  Two new mismatch 
recognition complexes have been synthesized.  The first, [Rh(bpy)2(phzi)]
3+ 
(phzi=benzo[a]phenazine-5,6-quinone diimine), recognizes DNA mismatches with 
high specificity and affinity, 1 × 107 m-1, two orders of magnitude stronger than 
[Rh(bpy)2(chrysi)]
3+ (chrysi=chrysene-5,6-quinone diimine), the parent complex that 
binds single thermodynamically-destabilized base-mismatch sites in duplex DNA.  The 
second, [Rh(bqdi)2(chrysi)]
3+, is able to recognize more stable mismatches such as the 
G-G mismatch.
These complexes have been applied in a variety of ways.  A method has been developed 
for the discovery of new single nucleotide polymorphisms, SNPs, within a sequence of 
interest amplified from pooled genomic DNA.  SNPs are readily detected using these 
mismatch selective molecules without false positives; allele frequencies as low as 0.05 
can be detected.  
Upon photoexcitation, the rhodium(III) diimine complexes cleave DNA by hydrogen 
atom abstraction from the sugar to yield 3’-phosphate terminated DNA that is inactive 
for enzymatic modification.  This 3’-phosphate can be removed using T4-polynucleotide 
kinase opening up the possibility of enzymatic modification at the site of rhodium 
cleavage.  The cleavage site can be fluorescently labeled.  Terminal transferase can also 
be used to attach a homopolymer tail tagging the damage site, allowing the amplification 
of the DNA up to the damaged site.
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This assay can also be employed towards the development of early cancer diagnostics.  
Some cancers are deficient in the repair of DNA base mismatches.  As a consequence, 
these cells have an increased number of mismatches within their genome.  These 
mismatches in extracted genomic DNA were cleaved using mismatch-specific rhodium 
complexes.  The cleavage sites were labeled with radioactivity, allowing the number 
of mismatch sites to be quantitated.  A significant number of sites were cleaved in the 
mismatch repair deficient DU145 cell line, 1 base/3000 bp, while no sites were cleaved in 
the mismatch repair proficient cell line SW620.  This method may present a new method 
for the detection of mismatch repair deficiency.
These mismatch-specific complexes also are shown to have an antiproliferative effect 
on mismatch repair deficient cell lines.  Mismatch repair deficiency is a contributing 
factor in both hereditary and sporadic human cancers.  Both [Rh(bpy)2(chrysi)]Cl3 and 
[Rh(bpy)2(phzi)]Cl3 show a stronger antiproliferative effect against MMR deficient cells 
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Chapter 1:  Introduction
1.1:  Introduction to deoxyribonucleic acid
 Deoxyribonucleic acid, DNA, is the genetic storage material of cells.  Very early 
genetic studies by Griffith showed that heat inactivated, cell free extracts from pathogenic 
bacteria could be used to transform nonpathogenic bacteria.1 The agent responsible for 
the transformation of these bacteria was purified and discovered to consist exclusively 
of deoxyribonucleic acid.2  This experiment, as well as others with eukaryotes, firmly 
established DNA as the primary carrier of genetic information.  
DNA is a long polymer of individual deoxyribonucleotides, each of which are 
composed of a base, a sugar and a phosphate, shown in figure 1.1.  The bases encode the 
genetic information while the sugar and phosphates participate in a structural role.  The 
bases present in DNA are adenine (A), thymine (T), guanine (G) and cytosine (C).  Early 
x-ray fiber diffraction studies were used by Watson and Crick to elucidate the double 
helical structure of DNA we know today.3  A DNA duplex is composed of two antiparallel 
DNA strands whose bases interact through hydrogen bonding and aromatic stacking.  
Because of the chemical functionalities presented, adenine pairs well with thymine and 
guanine with cytosine.  When so arranged, the base-paired units are virtually identical 
in width, 10.8 Å.  This initial model was later refined by single crystal x-ray diffraction 
studies.  
 The structure of DNA also solves the issue of genetic information inheritance.  
One DNA duplex can be used as a template for two identical duplexes.4  If the DNA 
duplex were opened, exposing the functionalities of the bases, complementary bases 
could be assembled to form a new complementary DNA.  By this process each DNA 
strand encodes for its own complement.  In vivo, DNA polymerases catalyze the reaction 
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Figure 1.1:  Deoxyribonucleic acid.  A.  Structures of the 4 natural DNA bases 
attached to a sugar phosphate backbone.  B.  The two Watson-Crick base pairs A-T and 
G-C and major and minor groove are indicated.  C.  When two complementary strands 
are annealed the DNA forms a B-form double helix.  Major and minor grooves are 
indicated.  Bases are colored grey with the sugar phosphate backbone in blue.
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template strand.5  In this way the original DNA duplex is copied, a necessary step in cell 
division.
 The copying of genetic material is a particularly important step in the 
reproduction of cells.  The primary focus of DNA polymerases is to replicate the parent 
DNA with as high a degree of fidelity as possible.6  If just the catalytic domain of a DNA 
polymerase were used to synthesize DNA, approximately 1 base is inserted incorrectly 
in 104 base pairs.7  This error rate is unacceptable for even the simplest of organisms 
which have genomes of ~106 base pairs, not to mention eukaryotes such as humans which 
have ~109 base pairs.8  In addition to the catalytic domain of DNA polymerase, several 
other mechanisms are employed to ensure high fidelity DNA replication.  First, the DNA 
polymerase enzyme also includes a proofreading domain which checks the base pairs 
immediately after DNA synthesis, excising those which are incorrectly incorporated.  
This boosts the fidelity of the DNA polymerase to 1 incorrect base in ~107–108 base pairs. 
Finally, postreplication repair extends the fidelity even further to <1 base pair in 109.7  
These incorrectly inserted bases, if not repaired, will form permanent mutations upon 
further DNA replication.
 These incorrectly inserted bases arise from two distinct sources.  First, bases 
within a dna strand9 as well as nucleotide triphosphate pools10 can undergo various 
chemical reactions within the cell such as oxidation, reduction, and alkylation.  These 
chemically modified bases present different functionalities and may not be recognized 
or inserted correctly by DNA polymerase.11  These errors are detected by primarily by 
base excision repair enzymes,12 and phosphatases to eliminate unnatural nucleotide 
triphosphates.10  The second source is from the incorrect insertion of a natural DNA base 
into an incorrect DNA base pair.  These mismatched base pairs are repaired by the MutS/
L “long patch” repair pathway.13
4
1.2:  Consequences of DNA mismatches
1.2.1:  Physical consequences of DNA mismatches
 DNA bases which are not paired with Watson-Crick partner are termed “base 
mismatches.”  These base mismatches are of considerable interest for their role in the 
formation of natural mutations.  The proposed hydrogen bonding structures are shown 
in figure 1.2.  Base mismatches in DNA have been studied by a variety of methods 
including x-ray crystallography, NMR, and melting temperatures.  Through these 
physical studies it is hoped that the mechanism by which mismatches are distinguished in 
vivo can be determined.  
 Several structures of DNA mismatches have been obtained by single crystal 
x-ray crystallography.  Structures of G-A,14 G-G,15 C-A,16 and G-T17 mismatches have 
been obtained, shown in figure 1.3.  All of the structures obtained have two internal 
mismatches and are modifications of the Drew-Dickerson dodecamer.18  these structures 
all show the DNA to be in essentially B-form conformation without kinks or extrahelical 
bases.  The individual mispaired bases do adopt unusual conformations in order to 
maximize their hydrogen bonding and aromatic stacking.  Some arguments have been 
made as to the validity of these crystal structures.  The only crystal structures obtained 
have been for more thermodynamically stable mismatches in a particularly stable duplex.  
Perhaps the reason these crystallize may be they are B-form while others are not.
In addition to x-ray crystallography, NMR studies have been undertaken to 
address concerns that the x-ray structures may have been exceptions.  NMR can be used 
to determine dynamics as well as structure of DNA molecules under more physiologically 
relevant conditions.19  Solution structures of various mismatched duplexes have 
confirmed that the overall structure of the DNA is essentially B-form in solution.  Varying 
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Figure 1.2:  Structures of the possible base pairs.  At the top we see the Watson-Crick 
base pairs, G-C and A-T, for comparison.  Below these are the various mismatches.
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Figure 1.3:  Crystal structures of DNA containing mismatched bases.  Four duplexes 
are labeled with the mismatch they contain, while the central duplex without a mismatch 
is shown for comparison.  The mismatched bases are highlighted in red.  The overall 
structure is not significantly perturbed, but those bases which are mismatched do vary 
slightly.
7
conformational changes of the mismatched bases, a switch occurs between two possible 
hydrogen bonding schemes.20; 21  initial 1H NMR studies have shown increased rates of 
solvent exchange of protons involved in hydrogen bonding.19  It is expected that in order 
for this solvent exchange to occur, mismatched bases must undergo a conformational 
change to expose the bases to bulk solvent.  This implies thermodynamic destabilization 
of the mismatched bases as compared to the natural DNA bases, a fact which can be 
quantitatively measured using variable temperature NMR.  Further NMR studies have 
confirmed that the mismatched bases undergo a conformational switch which occurs 
faster than the NMR time scale.21  However this occurs without disruption of the 
overall canonical B-form structure of the mismatched DNA.  Other local perturbations 
in dynamics are observed in addition to the mismatched bases.22  13C NMR relaxation 
studies have shown that base pairs adjacent to a mismatch experience a decrease in 
dynamical motion as compared to other Watson-Crick base pairs.21  
These structural studies have suggested that DNA containing a mismatch 
has an equilibrium structure which is essentially the same as standard B-form DNA.  
However, in solution the mismatched bases are seen to be more fluctional.  This 
suggests that perhaps when stress is applied to mismatched DNA, the DNA will form a 
kink at the mismatched site, as shown in figure 1.4.23  However no such kink has been 
experimentally observed.
 In addition to these structure and dynamics studies, mismatches have been studied 
energetically as well.24  Two sources of thermodynamic data are available, melting 
temperatures by UV spectroscopy, which gives data about the DNA duplex as a whole, 
and variable temperature NMR which can provide thermodynamic data about each 
individual base pair.  
 Melting temperature data were the first data to show that mismatches are 





Figure 1.4:  Schematic representation of the mismatched DNA bending theory.  
Two duplexes are shown on the left, matched and mismatched.  When these duplexes 
are subjected to bending, different results are proposed.  Matched DNA is thought 
to form a smooth bend under bending stress, while mismatched DNA, because of 
conformational flexibility, is thought to form a kink at the mismatch site.  Some believe 
that this helps mismatch repair proteins to locate mismatched base pairs.
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compare the stability of different mismatches quickly and easily.  This led to an initial 
ranking of the stability of different base pairs, G-C > A-T  > G-G ~ G-T ~ G-A > T-T ~ A-
A > C-T ~ C-A > C-C.20  These rankings do vary slightly depending on sequence context, 
but the trends remain similar.24  Guanine containing mismatches tend to be the most stable 
of mismatches, but are destabilizing as compared to the corresponding Watson-Crick 
base pair.  Their stability is attributed to the formation of strong hydrogen bonds and a 
large aromatic surface area.  The C-C mismatch is often the most destabilizing mismatch 
with weak hydrogen bonding low aromatic surface area.  Some have suggested the C-C 
mismatch can become protonated to form a wobble base pair, but this would involve 
the burying of a charge within the hydrophobic base stack of DNA. Using this method, 
standard thermodynamic parameters ΔH°, ΔS° and ΔG° of the melting transition can be 
determined.  NMR methods can provide even more data.  Using 1H NMR of the DNA 
imino region at different temperatures it is possible to determine melting temperatures of 
the individual bases in duplexes.19
 The combination of melting data with NMR data has allowed the creation of 
standard tables of ΔG° parameters of all base pairs in every sequence context, shown in 
table 1.1.  If we look at a particular duplex and ask how much can a single mismatch 
inserted into a duplex destabilize the DNA, the most destabilizing mismatch is a C-C 
mismatch in a 5’-ACT-3’ sequence context, where the C forms a C-C mismatch.  This 
particular mismatch destabilizes the DNA duplex by 2.7 kcal/mol.  We can also ask the 
inverse question, how much can a mismatch stabilize a duplex?  The G-G mismatch 
in a 5’-GGC-3’ sequence context stabilizes the duplex by -2.5 kcal/mol.  While this is 
stabilizing overall, this still falls short of a Watson-Crick G-C and A-T base pair which 
impart a -4.08 kcal/mol or -2.74 kcal/mol stabilization respectively.  In all cases, if a 
mismatch were replaced by a matched base pair it would have a stabilizing effect on 
the duplex.  This is illustrated by ΔG° parameters for all base pairs shown in sequence 
10
GX/CY A C G T
A 0.17 0.81 -0.25 -1.3
C 0.47 0.79 -2.24 0.62
G -0.52 -1.84 -1.11 0.08
T -1.44 0.98 -0.59 0.45
CX/GY A C G T
A 0.43 0.75 0.03 -1.5
C 0.79 0.7 -1.84 0.62
G 0.11 -2.17 -0.11 -0.5
T -1.28 0.4 -0.32 -0.1
AX/TY A C G T
A 0.61 0.88 0.14 -1
C 0.77 1.33 -1.44 0.64
G 0.02 -1.28 -0.13 0.71
T -0.88 0.73 0.07 0.69
TX/AY A C G T
A 0.69 0.92 0.42 -0.6
C 1.33 1.05 -1.3 0.97
G 0.74 -1.45 0.44 0.43
T -1 0.75 0.34 0.68
Table 1.1:  Thermodynamics of different mismatches.  ΔGº values(kcal/mol) 
for different internal mismatches with a neighboring matched base. In all cases 
the Watson-Crick base pairs, highlighted in yellow, are more stable than any of 
the possible mismatches.  To obtain a value for a mismatch, CC for example, in a 
sequence context, say 5’-GCG-3’ with 3’-CCC-5’ you would add 0.79 + 0.70 to 
obtain a net 1.49 kcal/mol destabilization.  X refers to the row while Y refers to the 
column.  
11
context in table 1.1.
1.2.2:  Biological sources and consequences of DNA mismatches
1.2.2.1:  Natural sources of DNA mismatches in vivo
 Mismatches are formed in vivo by a variety of processes.  DNA synthesis, 
genetic recombination, cytosine deamination and somatic hypermutation all produce 
mismatches to greater or lesser extents.  As previously mentioned, DNA synthesis is an 
extremely high fidelity process under normal circumstances, misincorporating a single 
base in 109 bases.8  More recent work has shown that under nonideal circumstances 
the misincorporation rate can be much higher.25  For example, humans have 14 known 
DNA polymerases.26  The majority of DNA synthesis occurs during the replication of 
the human genome by Polδ and/or Polε, very high fidelity polymerases.  However, these 
polymerases are incapable of replication of chemically damaged bases.  When these 
polymerases encounter a damaged base, they dissociate from the DNA and are replaced 
by a lower fidelity polymerase in a process known as translesion synthesis.27  translesion 
synthesis is performed by Polη in the case of pyrimidine dimers or Polι or Polζ in other 
cases.11  These polymerases are more permissive and therefore capable of incorporating 
a base across from a damaged base, but often an incorrect one.  These polymerases also 
lack 3’→5’ proofreading domains which in combination with their permissiveness can 
misincorporate a base in 10–103 base pairs.26  Translesion synthesis often only occurs for 
100–1000 base pairs after which the high fidelity polymerases continue synthesis.
 Genetic recombination is an essential process in meiosis which can also form 
DNA mismatches.  During recombination, homologous chromatids can form a crossover 
complex.28  This complex eventually forms a four way junction called a Holliday 
intermediate.  These junctions can “slide” exchanging a single strands between two 
12
homologous chromatids; often several thousand base pairs are exchanged.  If the DNA is 
not exactly identical, mismatches are produced.  Eventually an enzyme called a resolvase 
cuts the four way junction, which may or may not result in recombination, regardless, 
mismatches which were formed by four-way junction sliding remain.  This process 
accounts for some interesting non-Mendelian genetics, but it is not thought to be a major 
source of mismatches in vivo except in the case of germ cell production.
 Cytosine deamination is a natural chemical reaction whereby the minor imine 
tautomeric form of cytosine is hydrolysed to produce a uracil.29  This produces a G-U 
mispair which if left unpaired will result in an A-U and eventually an A-T base pair upon 
two rounds of DNA replication.  The G-U mispair is recognized and the uracil is removed 
by a base excision repair enzyme uracil DNA glycosylase, UDG.30  This generates an 
abasic site in the DNA which is repaired by an AP endonuclease and DNA polymerase.
 Intentional somatic mutation only occurs within a single eukaryotic cell type, B 
lymphocytes.  In the production of immunoglobulin several processes are used to increase 
diversity, one of which is somatic hypermutation, SHM.  During SHM variable regions 
of the immunoglobulin gene undergo mutations at a vastly higher rate of 1 base per 
1000 base pairs. While the exact mechanisms leading to SHM are not fully understood 
it appears that DNA mismatches are a necessary component.  It is currently believed 
that SHM occurs by the action of a activation-induced cytosine deaminase, AID.29  this 
enzyme catalyzes the conversion of cytosine to uracil in single stranded DNA.  Because 
of intentional incomplete repair this process can lead to G-U mismatches and abasic sites 
during DNA replication, which produce all possible mutations upon replication.31
1.2.2.2:  Fate and consequences of mismatches
 In general, DNA mismatches in vivo are recognized and repaired by MutS/L/H 
DNA repair pathway or homologs in higher organisms.32  This pathway, also known 
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simply as mismatch repair, MMR, detects a mismatch and replaces the ~1 kb of DNA in 
the process. This type of DNA repair is present in all organisms from E. coli to humans.
   In this pathway, shown in figure 1.5, a MutS dimer recognizes a mispaired base 
and binds the DNA.  MutS or its homologs are able to recognize most DNA mismatches 
although some mismatches such as C-C are not detected.  A MutL dimer can then bind 
to the MutS dimer signaling and coordinating a mismatch repair event.  This MutS/L 
complex discriminates parent strand from daughter strand by a poorly understood process 
and then recruits muth, or an as yet unknown endonuclease in eukaryotes, to nick the 
mispaired daughter strand.  The nicked strand is digested by exonucleases in either 5’→
3’ or 3’→5’ directions towards the mismatched base.  Finally, a new DNA strand is 
synthesized by a DNA polymerase followed by a ligation to seal the patch.  In addition to 
the role of MMR in DNA repair, the associated proteins also can trigger cell cycle arrest 
or apoptosis.33  
 If mismatches are not repaired before another round of DNA replication, the 
mismatch will become a permanent mutation.  Under normal circumstances this would 
be a rare event, but if mismatch repair were somehow deactivated this process is 
significantly enhanced.  This MMR deficient phenotype has been observed in numerous 
types of cancer.34
1.3:  Recognition of DNA mismatches, enzymes
 Recognition of mismatched natural DNA bases occurs primarily by MutS 
dimer or heterodimer of homologs in higher organisms.32  However, there is a second 
specialized protein which recognizes only G-T mismatches formed from cytosine 
deamination.  This protein is the very short patch repair protein Vsr.35  These two proteins 
have been studied by a variety of biochemical and structural methods, the results of 
which show a remarkable contrast in two strategies for mismatch recognition.  
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Figure 1.5:  Mismatch repair in prokaryotes.  A general scheme outlining 
the major steps in mismatch repair.  A similar process is believed to occur in 
eukaryotes.  MutS finds a mismatch base and is bound by MutL.  MutL activates 
MutH to nick the mismatched daughter strand on either the 5’ or 3’ side of the 
mismatch.  Exonucleases digest the DNA to the mismatched site.  DNA polymerase 































































 MutS is responsible for the initial binding event which is then recognized by 
other members of the mismatch repair pathway to signal a lesion to repair.  DNA-protein 
interactions have been studied by a variety of biochemical and structural methods.  While 
the method by which mismatches are recognized is not clear, significant progress has 
been made in this field.
 Recently, two structures of the MutS protein bound to mismatched substrate 
have been obtained, one from E. coli36 and the other from T. aquaticus37.  The structures 
shows a clamp structure which grabs the DNA and kinks the DNA duplex at a rather 
severe 60° angle.  This kinking of duplex causes the DNA to adopt a structure which 
shows the typical features of A form DNA.  The primary interaction with the DNA is 
through electrostatic interactions of the DNA with the high positive charge of the interior 
of the MutS protein.  These interactions are supplemented by a phenylalanine which is 
intercalated in the DNA at the mismatch.38  
 This has led to the theory that MutS finds mismatched bases by forming a sliding 
clamp which bends the DNA as it slides looking for sites which are especially easy to 
bend.23  This theory is supported by NMR data suggesting increased flexibility of the 
DNA at mismatched sites.21  This theory however is not supported by the repair activity 
of MutS.39  MutS has been found to have high repair activity toward G-T mismatches and 
almost none against C-C mismatches.  The G-T mismatch is among the most stable and 
would be predicted by this theory to be inefficiently repaired.  The C-C mismatch is very 
destabilized and would be predicted to be repaired very well.
 AFM studies were carried out using MutS with matched and mismatched 
DNA.40  While these samples were dried onto a mica substrate and therefore not under 
physiological conditions, an intriguing result was obtained.  When matched DNA binds 
to MutS, it does so in the kinked form.  However, when mismatched DNA is bound to 
MutS, it is in equilibrium between two states, kinked and unkinked.  This bent/unbent 
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equilibrium delicately balances the stabilization from the insertion of the phenylalanine 
versus the destabilized unkinked protein conformation in the linear DNA form. 
This gives at least a tenuous explanation of why pyrimidine-pyrimidine mismatches 
are not recognized.  Since there is little or no stabilization from the insertion of the 
phenylalanine, the equilibrium is placed toward the bent conformation.  This unkinked 
form is proposed to be the ultimate recognition complex to which MutL binds, but this 
has not yet been confirmed.
 These studies also suggest that overall there is little difference in binding affinity 
of MutS for matched or mismatched DNA.  Instead the protein remains bound to the 
DNA with or without mismatch present.  The recognition event is likely not protein 
binding, but rather the change in protein conformation upon mismatch binding that begins 
DNA mismatch repair.
 The very short patch repair takes a completely different approach to finding 
mismatches.  The Vsr protein only repairs G-T mismatches which are produced from 
5-methylcytosine deamination in E. coli.41  5-methylcytosine is created in some bacteria 
by the Dcm methylase as part of a phage resistance mechanism involving methylation 
dependent restriction endonucleases.42  5-methylcytosine has the unfortunate consequence 
that when deamination occurs it becomes a natural DNA base, unlike unmethylated 
cytosine which will become uracil.  Upon recognition of a G-T mismatch, Vsr nicks the 
DNA on the 5’ side of the mismatch.  DNA polymerase I binds this nick and performs a 
nick translation reaction repairing the mismatch.  The single strand break is then sealed 
by a DNA ligase.  The cytosine is then methylated by the dcm methylase.
 Recently, a crystal structure of the Vsr enzyme bound to DNA was obtained.41  
This shows a structure which is remarkably similar to a type II restriction enzyme.  
However, the enzyme binds to the mismatched DNA as a monomer.  Numerous 
electrostatic and hydrogen bond contacts are made with the DNA.  The mismatch is 
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discriminated by the insertion of an aromatic wedge composed of two tryptophans and 
a phenylalanine.  This insertion causes a large distortion in the DNA, a gap of 6 Å and a 
44° kink forcing the site to be probed into the restriction enzyme catalytic pocket.  Here 
the G-T mismatch is discriminated from the G-C base pair by conformation.  If the G-T 
wobble base pair is bound, its distorted structure will cause the phosphodiester linkage 
into the endonuclease pocket cleaving the substrate.  Remarkably this enzyme is able to 
perform this discrimination without the use of ATP, inferring that the recognition process 
is a thermodynamically favorable one, although it is possible that the cleaved enzyme-
DNA complex cannot dissociate without assistance.  This protein is also an example of 
damage recognition without extrahelical bases which are present in MutS, uracil DNA 
glycosylase and MutY.43  This lack of base flipping may be the reason that this protein is 
able to recognize a mismatch without external energy.
1.4:  Recognition of DNA mismatches, small molecules
 Several small molecule methods of mismatch recognition have also been 
developed.  The ways in which these small molecules recognize mismatched DNA 
vary.  Many compounds which bind matched DNA duplexes also will bind mismatched 
substrates as well.  For example the classic intercalator ethidium bromide44 and the minor 
groove binding DAPI45 are capable of binding mismatched as well as matched DNA with 
similar affinity.  For the purposes of this section, only compounds which are capable of 
recognition of mismatches in preference to matched DNA will be discussed.
1.4.1:  Mismatch recognition using polyamides
 Polyamides are capable of the recognition of mismatched bases through minor 
groove interactions.46  Work within the Dervan group have generated methods to 
target polyamides to virtually any sequence within DNA.  Since the polyamides form 
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interactions with bases of both strands, one must only insert the proper building blocks 
to recognize a mismatched base pair.  This method depends on multiple interactions 
however and so can only recognize a particular mismatch within a given sequence.
 This method has been successfully applied to the recognition of G-T mismatches 
within DNA by the polyamide f-ImImIm.47  This compound binds within the minor 
groove of DNA as a dimer.  Binding of the compound in the minor groove can be 
observed by DNAse I footprinting48 and by surface plasmon resonance.  Surface plasmon 
resonance measurements can be used to calculate binding constants of 6 × 106 m-1 for 
the G-T mismatch.  This complex has a significantly decreased affinity towards matched 
DNA (CCGG), 2.1 × 105 m-1 or non-cognate sequences (AATT) 6 × 103 m-1.
1.4.2:  Mismatch recognition using naphthyridine
 Work within the Saito and Nakatani groups have focused on the use of the 
naphthyridine moiety.  Originally, 2-amino-7-methylnaphthyridine was shown to 
stabilize single guanine bulges.49  The mechanism proposed for this stabilization was by 
the intercalation of the naphthyridine moiety across from the bulged base and forming 
strong hydrogen bonds with the bulged guanine base.  The nitrogens of the naphthyridine 
hydrogen bond with the guanine stabilizing its interaction with the DNA, as shown in 
figure 1.6A.  The DNA is stabilized through aromatic stacking of the naphthyridine.
 In addition to bulges, dimers of naphthyridine, formed by attaching a alkyl 
linker between two exocyclic amine groups, are able to recognize a variety of different 
mismatches.  G-G mismatches are readily recognized by an amide linked naphthyridine 
dimer.50  The interaction of this dimer with the G-G mismatch is very similar to the single 
guanine bulge mentioned above.  Specific interaction with the bases of the G-G mismatch 
is observed by DNAse I footprinting assays.51  The two naphthyridine moieties insert 


































































Figure 1.6:  Naphthyridine dimer structures and interactions with 
mismatches.  Two different naphthyridine dimers have been constructed which 
bind mismatches.  In A an amide linked structure will bind to G-G mismatches.  
In B an alkyl linked strcuture will bind to C-C mistmatches because of the shift 
in pKa associated with the different linker.
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interaction can be observed readily using NOESY.50  For quantitative measurements 
of binding surface plasmon resonance was employed.52  Naphthyridine dimer was 
functionalized to a SPR substrate and mismatched DNA was applied in solution.  This 
method allows for the measurement of both binding rates and dissociation rates from 
which kd can be calculated.  These complexes bind the G-G mismatch tightly with 
affinities of 0.1–4 × 106 m-1, depending on sequence context.
 A modification of the original dimer, linked through an alkyl chain rather than 
an amide bond was also synthesized, shown in figure 1.6b.53  This compound is able 
to recognize C-C mismatches in addition to a few others: C-T, C-A, and T-T.  This is 
surprising considering that the recognition element remains the same, but only the linker 
is changed.  This has been explained by conducting experiments while varying pH.  It 
is believed that the recognition of the C-C mismatch is accomplished by protonation 
of a heterocyclic amine.  Affinities for this molecule are also quite high, 1–8 × 106 m-1, 
again varying with sequence context.  It is not completely specific for the C-C mismatch; 
C-T, C-A and T-T mismatches are all bound with decreased affinity.  Additionally fully 
matched duplexes are also recognized with about an 80-fold lower affinity.
1.4.3:  Mismatch recognition using metallointercalators
1.4.3.1:  Metallointercalator background
 Previous work within the Barton group has focused on the use of coordinatively 
saturated d6 octahedral metal complexes and their interactions with DNA.54  these 
compounds can interact with DNA by a variety of different routes.  Compounds 
such as [Ru(bpy)3]Cl2 interact only weakly with DNA via electrostatic interactions.  
Using ligands with a larger aromatic surface area such as [Ru(phen)3]Cl2 can result in 
minor groove binding where some aromatic surface area becomes buried within the 
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hydrophobic DNA minor groove.  Finally some complexes such as [Ru(bpy)2(dppz)]Cl2 
or [Rh(bpy)2phi]Cl3 where a large aromatic ligand extends further from the metal center 
can interact with DNA via intercalation from the major groove.
 Since these complexes are low-spin d6, they are coordinatively saturated and 
inert to substitution.  This inertness and definite geometry allows for the construction of 
complexes with a rational positioning of functional groups.  In this way we can divide the 
complexes into several pieces: the intercalating ligand, ancillary ligands and the metal 
center.  
 The intercalating ligand, typically a large planar heterocycle, forms the basis 
for the majority of the affinity the complex has for DNA.  The source of this affinity is 
several-fold.  First interactions of the hydrophobic ligand with the hydrophobic interior of 
the DNA base stack through van der Waals contacts contribute to the stabilization of the 
interaction.  Second, removing the large aromatic surface area from the water causes the 
release of ordered waters whose increased entropy likely more than offsets the decrease 
in entropy from binding.  Lastly, the interaction with the DNA is strengthened by strong 
dipole-dipole interactions, through fixed dipoles of the DNA and metal complex. 
 Ancillary ligands can serve two functions.  First, they donate several electron 
pairs which allow us to form a coordinatively saturated complex.  Beyond this, they can 
simply be innocent bystanders in the interaction with DNA, or can provide functionality 
which modifies the interaction of the complex with DNA.  If we choose a ancillary ligand 
such as 2,2’-bipyridine, bpy, this ligand has little functionality which can interact with 
the DNA.  On the other hand if we choose a ligand such as ethylene diamine, this ligand 
provides a hydrogen bond donor to the complex.55  This ligand produces a favorable 
hydrogen bond with guanines increasing its affinity toward certain sequences in the DNA. 
Unfavorable interactions are also possible, in the case of 1,10-phenanthroline, phen, an 
unfavorable steric clash between the 2 and 9 hydrogens of the phenanthroline ring with 
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functionalities on the DNA causes this complex to bind to 5’-pyrimidine-pyrimidine-
purine-3’ sequences.56  
 Finally, the center of the octahedral complex, the metal ion, serves multiple 
purposes.  In general, rhodium (III) is the metal ion of choice, although others have been 
used such as ruthenium (II), iridium (III), osmium (III) and nickel (II).  Each metal ion 
has its own unique abilities when used to make a metallointercalator.  Rhodium (III) 
complexes with a diimine intercalating ligand, such as phi, can cleave DNA at their 
intercalated site by irradiation with UV light.57  The UV excitation causes a ligand to 
metal charge transfer forming a ligand radical capable of hydrogen atom abstraction 
at the intercalated site.58  Ruthenium(II) complexes are typically used for their unique 
photophysical properties.  Tris diimine complexes, such as the light switch compound 
[Ru(bpy)2(dppz)]Cl3, when excited by visible light can emit luminescence.
59  these 
compounds can also be used as photooxidants when an appropriate external quencher 
is added.60  Nickel(II) complexes have been used because they are paramagnetic which 
makes them useful for NMR studies.61
 An example of designed interactions with DNA is the complex Δ-α-[Rh(R,R-
2,9-dimethyl-trien)(phi)]3+, shown in figure 1.7.62  The metal of choice for this complex 
was rhodium(III) for both for photocleavage and substitutional inertness.  This complex 
uses the phi intercalating ligand which provides a basis for the interaction of the complex 
with the DNA.  The ancillary ligand adds many interactions to the complex.  The 
triethylenetetraamine (trien) ligand provides axial amines similar to ethylene diamine, 
and similarly hydrogen bonds to 5’-GC-3’ base steps.  To this ligand two methyl groups 
are added.  These methyl groups are designed to interact favorably with the methyl 
groups of thymine.  This makes a compound which is designed to bind to the overall 
sequence 5’-TGCA-3’.  
 This compound does bind the designed cognate sequence.  Upon UV irradiation 
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Figure 1.7:  ∆-α-[Rh(R,R-dimethyl-trien)(phi)]3+.  Shown on the left is 
the complex with the stereochemistry shown.  On the right is the complex 
schematically interacting with the cognate 5’-TGCA-3’ sequence.  Axial 
amines hydrogen bond with the O6 of guanine.  The methyl groups are shown 
interacting with the methyl group of thymine.
24
Figure 1.8:  Crystal structure of ∆-α-[Rh(R,R-dimethyl-trien)(phi)]3+ bound to 
DNA.
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this compound is cleaves at the 5’-TGCA-3’ site with moderate photoefficiency.  Using a 
titration it is possible to determine the binding constant of 9 × 107 m-1 for this complex to 
the desired sequence.63
 This high affinity and specificity were key factors in obtaining both a crystal 
structure64 and nmR structure65 of this complex with its cognate DNA, shown in figure 
1.8.  Using the crystal structure we are able to verify the various designed interactions.  
Additionally this structure conclusively demonstrates that the phi ligand intercalates from 
the major groove with an untwisting of the DNA.  The phi ligand is buried with almost no 
free space between the ligand and the sugar rings.  
1.4.3.2:  Mismatch recognition by metallointercalators
 Using the principles outlined above metallointercalators were synthesized which 
are able to bind DNA mismatches.  Similar to the phenanthroline complex described 
above, mismatches were targeted by creating a ligand which would have an unfavorable 
interaction at any intercalated site other than the destabilized mismatch site.
 This was achieved not by modification of the ancillary ligands, but by 
modification of the intercalating ligand.  As seen from the crystal structure, the phi ligand 
forms a tight complex with matched DNA.  As seen in the space filling model, it is the 
perfect size for intercalation, filling all available space within the intercalation site.  If 
we were to expand the width of the intercalating ligand, the intercalating ligand would 
sterically clash with sugar rings.  This would be energetically prohibitive for the complex 
to bind to matched sites.  At destabilized sites such as mismatches, intercalation may be 
possible.  As the ligand intercalates steric clash with the sugar rings will be inevitable.  
If the mismatched bases are significantly destabilized, the loss of hydrogen bonding 
between the bases may be more than offset by increased aromatic stacking, dipole 
interactions and removing the ligand from water.
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HN NH HN NH
9.16 Å 11.3 Å
Figure 1.9:  Intercalated phi ligand and comparison to chrysi.  At the top 
a view of the intercalated phi ligand from crystal structure data.  There is little 
room for expansion as the phi ligand already makes contact with the oxygen of 
the sugar ring.  At the bottom is a comparison of the widths of the phi ligand and 
chrysi ligand.  The addition of a fourth ring will make the intercalator too large to 
intercalate at stable sites in the dna
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 This design was implemented by modifying the phi intercalating ligand, fusing 
another ring to form chrysene quinone diimine, chrysi, shown in figure 1.9.66  This ligand 
was incorporated into a rhodium(III) complex, [Rh(bpy)2(chrysi)]Cl3, Rhchrysi.  This 
compound was found to bind mismatches with moderate affinity 1 × 105 m-1 and high 
specificity; mismatches are bound ~1000 times tighter than matched base pairs. 
 A series of experiments were conducted to determine which mismatches are 
recognized by this complex.  In addition to the mismatch itself, base pairs surrounding 
the mismatch site, the sequence context, of the mismatch were also varied.  The sequence 
context has a profound effect on mismatch stability as shown previously. The conclusion 
of these studies was that Rhchrysi bound 80% of all possible mismatches.  When the 
cleavage intensity is plotted against mismatch stability, we can see a clear effect of 
mismatch stability on the binding and cleavage of [Rh(bpy)2(chrysi)]Cl3.
67
 Additional studies were undertaken to determine just how far this complex could 
be pressed as far as specificity.  For these experiments, two plasmids were created which 
differed at one site in 2725 base pairs.  These plasmids were linearized, denatured and 
annealed to form a mismatch at the desired site.  Using an alkaline agarose gel, cleavage 
can be seen, at a single site, approximately corresponding to the mismatch site.  If this 
duplex is further restricted and run on a denaturing polyacrylamide gel, we can see that 
the mismatch site, and only the mismatch site, is cleaved within the whole plasmid, 
shown in figure 1.10.68
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Figure 1.10:  Specific cleavage of a single mismatch in a 2725 base pair 
plasmid.  Two plasmids were created which differed by a single G → C base 
substitution.  These were linearized, denatured and annealed to form a C-C 




1. Griffith, F. (1928). The significance of pneumococcal types. J. Hyg. 27, 113-159.
2. Avery, O. T., MacLeod, C. M., McCarty, M. (1944). Chemical nature of 
the substance inducing transformation of pneumococcal types. Induction of 
transformation by a desoxyribonucleic acid fraction isolated from pneumococcus 
Type III. J. Exp. Med. 79, 137-158.
3. Watson, J. D., Crick, F. H. (1953). Molecular structure of nucleic acids; a structure 
for deoxyribose nucleic acid. Nature 171, 737-738.
4. Watson, J. D., Crick, F. H. (1953). Genetical implications of the structure of 
deoxyribonucleic acid. Nature 171, 964-967.
5. Friedberg, E. C. (2006). The eureka enzyme: The discovery of DNA polymerase. 
Nat. Rev. Mol. Cell. Biol. 7, 143-7.
6. Kunkel, T. A. (2004). DNA replication fidelity. J. Biol. Chem. 279, 16895-16898.
7. Schaaper, R. M. (1993). Base selection, proofreading, and mismatch repair during 
DNA replication in Escherichia coli. J. Biol. Chem. 268, 23762-23765.
8. Drake, J. W., Charlesworth, B., Charlesworth, D., Crow, J. F. (1998). Rates of 
spontaneous mutation. Genetics 148, 1667-1686.
9. Burrows, C. J.,  Muller, J. G. (1998). Oxidative nucleobase modifications leading 
to strand ccission. Chem. Rev. 98, 1109-1152.
10. Russo, M. T., Blasi, M. F., Chiera, F., Fortini, P., Degan, P., Macpherson, P., 
Furuichi, M., Nakabeppu, Y., Karran, P., Aquilina, G., Bignami, M. (2004). The 
oxidized deoxynucleoside triphosphate pool is a significant contributor to genetic 
instability in mismatch repair-deficient cells. Mol. Cell. Biol. 24, 465-474.
11. Prakash, S., Johnson, R. E., Prakash, L. (2005). Eukaryotic translesion synthesis 
DNA polymerases: Specificity of structure and function. Annu. Rev. Biochem. 74, 
317-353.
30
12. Berti, P. J., McCann, J. A. (2006). Toward a detailed understanding of base 
excision repair enzymes: transition state and mechanistic analyses of N-glycoside 
hydrolysis and N-glycoside transfer. Chem. Rev. 106, 506-555.
13. Iyer, R. R., Pluciennik, A., Burdett, V., Modrich, P. L. (2006). DNA mismatch 
repair: functions and mechanisms. Chem. Rev. 106, 302-323.
14. Brown, T., Hunter, W. N., Kneale, G., Kennard, O. (1986). Molecular structure of 
the G.A base pair in DNA and its implications for the mechanism of transversion 
mutations. Proc. Natl. Acad. Sci. USA 83, 2402-2406.
15. Skelly, J. V., Edwards, K. J., Jenkins, T. C., Neidle, S. (1993). Crystal structure of 
an oligonucleotide duplex containing G.G base pairs: influence of mispairing on 
DNA backbone conformation. Proc. Natl. Acad. Sci. USA 90, 804-808.
16. Hunter, W. N., Brown, T., Kennard, O. (1987). Structural features and hydration 
of a dodecamer duplex containing two C.A mispairs. Nucleic Acids Res. 15, 6589-
6606.
17. Hunter, W. N., Brown, T., Kneale, G., Anand, N. N., Rabinovich, D., Kennard, 
O. (1987). The structure of guanosine-thymidine mismatches in B-DNA at 2.5Å 
resolution. J. Biol. Chem. 262, 9962-9970.
18. Drew, H. R., Wing, R. M., Takano, T., Broka, C., Tanaka, S., Itakura, K., 
Dickerson, R. E. (1981). Structure of a B-DNA dodecamer: Conformation and 
dynamics. Proc. Natl. Acad. Sci. USA 78, 2179-2183.
19. Arnold, F. H., Wolk, S., Cruz, P., Tinoco, I., Jr. (1987). Structure, dynamics, and 
thermodynamics of mismatched DNA oligonucleotide duplexes d(CCCAGGG)2 
and d(ccctggg)2. Biochemistry 26, 4068-4075.
20. Peyret, N., Seneviratne, P. A., Allawi, H. T., SantaLucia, J., Jr. (1999). Nearest- 
neighbor thermodynamics and NMR of DNA sequences with internal A.A, C.C, 
G.G, and T.T mismatches. Biochemistry 38, 3468-3477.
31
21. Isaacs, R. J., Rayens, W. S. & Spielmann, H. P. (2002). Structural differences in 
the NOE-derived structure of G-T mismatched DNA relative to normal DNA are 
correlated with differences in 13C relaxation-based internal dynamics. J. Mol. Biol. 
319, 191-207.
22. Isaacs, R. J., Spielmann, H. P. (2004). Insight into G-T mismatch recognition 
using molecular dynamics with time-averaged restraints derived from NMR 
spectroscopy. J. Am. Chem. Soc. 126, 583-590.
23. Isaacs, R. J., Spielmann, H. P. (2004). A model for initial DNA lesion recognition 
by NER and MMR based on local conformational flexibility. DNA Repair (Amst.) 
3, 455-464.
24. SantaLucia, J., Jr., Hicks, D. (2004). The thermodynamics of DNA structural 
motifs. Annu. Rev. Biophys. Biomol. Struct. 33, 415-440.
25. Wang, G., Alamuri, P., Humayun, M. Z., Taylor, D. E., Maier, R. J. (2005). 
the Helicobacter pylori MutS protein confers protection from oxidative DNA 
damage. Mol. Microbiol. 58, 166-176.
26. Kunkel, T. A. (2003). Considering the cancer consequences of altered DNA 
polymerase function. Cancer Cell 3, 105-110.
27. Lehmann, A. R. (2005). Replication of damaged DNA by translesion synthesis in 
human cells. FEBS Lett. 579, 873-876.
28. Gerton, J. L., Hawley, R. S. (2005). Homologous chromosome interactions in 
meiosis: diversity amidst conservation. Nat. Rev. Genet. 6, 477-487.
29. Samaranayake, M., Bujnicki, J. M., Carpenter, M., Bhagwat, A. S. (2006). 
Evaluation of molecular models for the affinity maturation of antibodies: Roles of 
cytosine deamination by AID and DNA repair. Chem. Rev. 106, 700-719.
30. Wibley, J. E., Waters, T. R., Haushalter, K., Verdine, G. L., Pearl, L. H. (2003). 
Structure and specificity of the vertebrate anti-mutator uracil-DNA glycosylase 
32
SMUG1. Mol. Cell. 11, 1647-1659.
31. Seki, M., Gearhart, P. J., Wood, R. D. (2005). DNA polymerases and somatic 
hypermutation of immunoglobulin genes. EMBO Rep. 6, 1143-1148.
32. Kunkel, T. A., Erie, D. A. (2005). DNA mismatch repair. Annu. Rev. Biochem. 74, 
681-710.
33. O’Brien, V., Brown, R. (2006). Signalling cell cycle arrest and cell death through 
the MMR System. Carcinogenesis 27, 682-692.
34. Arzimanoglou, II, Gilbert, F., Barber, H. R. (1998). Microsatellite instability in 
human solid tumors. Cancer 82, 1808-1820.
35. Bhagwat, A. S., Lieb, M. (2002). Cooperation and competition in mismatch 
repair: Very short-patch repair and methyl-directed mismatch repair in 
Escherichia coli. Mol. Microbiol. 44, 1421-1428.
36. Lamers, M. H., Perrakis, A., Enzlin, J. H., Winterwerp, H. H., de Wind, N., 
Sixma, T. K. (2000). The crystal structure of DNA mismatch repair protein MutS 
binding to a G-T mismatch. Nature 407, 711-717.
37. Obmolova, G., Ban, C., Hsieh, P., Yang, W. (2000). Crystal structures of mismatch 
repair protein MutS and its complex with a substrate DNA. Nature 407, 703-710.
38. Yamamoto, A., Schofield, M. J., Biswas, I., Hsieh, P. (2000). Requirement for 
Phe36 for DNA binding and mismatch repair by Escherichia coli MutS protein. 
Nucleic Acids Res. 28, 3564-3569.
39. Brown, J., Brown, T., Fox, K. R. (2001). Affinity of mismatch-binding protein 
MutS for heteroduplexes containing different mismatches. Biochem. J. 354, 627-
633.
40. Wang, H., Yang, Y., Schofield, M. J., Du, C., Fridman, Y., Lee, S. D., Larson, E. 
D., Drummond, J. T., Alani, E., Hsieh, P., Erie, D. A. (2003). DNA bending and 
unbending by MutS govern mismatch recognition and specificity. Proc. Natl. 
33
Acad. Sci. USA 100, 14822-14827.
41. Tsutakawa, S. E., Jingami, H., Morikawa, K. (1999). Recognition of a TG 
mismatch: The crystal structure of very short patch repair endonuclease in 
complex with a DNA duplex. Cell 99, 615-623.
42. Lieb, M., Bhagwat, A. S. (1996). Very short patch repair: reducing the cost of 
cytosine methylation. Mol. Microbiol. 20, 467-473.
43. Morikawa, K., Shirakawa, M. (2000). Three-dimensional structural views of 
damaged-DNA recognition: T4 endonuclease V, E. coli Vsr protein, and human 
nucleotide excision repair factor XPA. Mutat. Res. 460, 257-275.
44. Hernandez, L. I., Zhong, M., Courtney, S. H., Marky, L. A., Kallenbach, N. 
R. (1994). Equilibrium analysis of ethidium binding to DNA containing base 
mismatches and branches. Biochemistry 33, 13140-13146.
45. Trotta, E., Paci, M. (1998). Solution structure of DAPI selectively bound in the 
minor groove of a DNA T.T mismatch-containing site: NMR and molecular 
dynamics studies. Nucleic Acids Res, 26, 4706-4713.
46. Dervan, P. B., Edelson, B. S. (2003). Recognition of the DNA minor groove by       
pyrrole-imidazole polyamides. Curr. Opin. Struct. Biol. 13, 284-299.
47. Lacy, E. R., Cox, K. K., Wilson, W. D., Lee, M. (2002). Recognition of T*G 
mismatched base pairs in DNA by stacked imidazole-containing polyamides: 
surface plasmon resonance and circular dichroism studies. Nucleic Acids Res. 30, 
1834-1841.
48. Lacy, E. R., Nguyen, B., Le, M., Cox, K. K., C, O. H., Hartley, J. A., Lee, 
M., Wilson, W. D. (2004). Energetic basis for selective recognition of T*G 
mismatched base pairs in DNA by imidazole-rich polyamides. Nucleic Acids Res. 
32, 2000-2007.
49. Nakatani, K., Sando, S., Saito, I. (2000). Recognition of a single guanine bulge by 
34
2-acylamino-1,8-naphthyridine. J. Am. Chem. Soc. 122, 2172-2177.
50. Nakatani, K., Sando, S., Kumasawa, H., Kikuchi, J. & Saito, I. (2001). 
Recognition of guanine-guanine mismatches by the dimeric form of 2-amino-1,8-
naphthyridine. J. Am. Chem. Soc. 123, 12650-12657.
51. Nakatani, K., Sando, S., Saito, I. (2001). Improved selectivity for the binding of 
naphthyridine dimer to guanine-guanine mismatch. Bioorg. Med. Chem. 9, 2381-
2385.
52. Nakatani, K., Sando, S., Saito, I. (2001). Scanning of guanine-guanine 
mismatches in DNA by synthetic ligands using surface plasmon resonance. Nat. 
Biotechnol. 19, 51-55.
53. Kobori, A., Nakatani, K., Saito, I. (2003). Detection of a C-C mismatched base 
pair by SPR assay using sensors immobilized with a cytosine-specific ligand. 
Biochemistry 42, 8610.
54. Erkkila, K. E., Odom, D. T., Barton, J. K. (1999). Recognition and reaction of    
metallointercalators with DNA. Chem. Rev. 99, 2777-2795.
55. Krotz, A. H., Kuo, L. Y., Shields, T. P., Barton, J. K. (1993). DNA recognition by 
rhodium(III) polyamine intercalators: Considerations of hydrogen-bonding and 
van der Waals interactions. J. Am. Chem. Soc. 115, 3877-3882.
56. Sitlani, A., Long, E. C., Pyle, A. M., Barton, J. K. (1992). DNA photocleavage 
by phenanthrenequinone diimine complexes of rhodium(III): Shape-selective 
recognition and reaction. J. Am. Chem. Soc. 114, 2303-2312.
57. Pyle, A. M., Long, E. C., Barton, J. K. (1989). Shape-selective targeting of DNA 
by (phenanthrenequinone diimine)rhodium(III) photocleaving agents. J. Am. 
Chem. Soc. 111, 4520-4522.
58. Turro, C., Hall, D. B., Chen, W., Zuilhof, H., Barton, J. K., Turro, N. J. (1998). 
Solution photoreactivity of phenanthrenequinone diimine complexes of rhodium 
35
and correlations with DNA photocleavage and photooxidation. J. Phys. Chem. A 
102, 5708-5715.
59. Hartshorn, R. M., Barton, J. K. (1992). Novel dipyridophenazine complexes of 
ruthenium(II): Exploring luminescent reporters of DNA. J. Am. Chem. Soc. 114, 
5919-5925.
60. Stemp, E. D. A., Arkin, M. R., Barton, J. K. (1997). Oxidation of guanine in DNA 
by [Ru(phen)2(dppz)]
3+ using the flash-quench technique. J. Am. Chem. Soc. 119, 
2921-2925.
61. Rehmann, J. P., Barton, J. K. (1990). 1H NMR studies of tris(phenanthroline) 
metal-complexes bound to oligonucleotides: Structural characterizations via 
selective paramagnetic relaxation. Biochemistry 29, 1710-1717.
62. Krotz, A. H., Barton, J. K. (1994). Rational construction of metallointercalators:    
Syntheses, structures, and characterizations of isomers of ((2s,9s)-diamino-4,7-
diazadecane)(9,10-phenanthrenequinone diimine)rhodium(III). Inorg. Chem. 33, 
1940-1947.
63. Krotz, A. H., Hudson, B. P., Barton, J. K. (1993). Assembly of DNA recognition    
elements on an octahedral rhodium intercalator: Predictive recognition of 5’-
TGCA-3’ by Δ-[Rh[(R,R)-Me2trien]Phi]
3+. J. Am. Chem. Soc. 115, 12577-12578.
64. Kielkopf, C. L., Erkkila, K. E., Hudson, B. P., Barton, J. K., Rees, D. C. (2000). 
Structure of a photoactive rhodium complex intercalated into DNA. Nat. Struct. 
Biol. 7, 117-121.
65. Hudson, B. P., Barton, J. K. (1998). Solution structure of a metallointercalator 
bound site specifically to DNA. J. Am. Chem. Soc. 120, 6877-6888.
66. Jackson, B. A., Barton, J. K. (1997). Recognition of DNA base mismatches by a 
rhodium intercalator. J. Am. Chem. Soc. 119, 12986-12987.
67. Jackson, B. A., Barton, J. K. (2000). Recognition of base mismatches in DNA by 
36
5,6-chrysenequinone diimine complexes of rhodium(III): A proposed mechanism 
for preferential binding in destabilized regions of the double helix. Biochemistry 
39, 6176-6182.
68. Jackson, B. A., Alekseyev, V. Y., Barton, J. K. (1999). A versatile mismatch 
recognition agent: Specific cleavage of a plasmid DNA at a single base mispair. 
Biochemistry 38, 4655-4662.
37
Chapter 2:  Metallointercalators
2.1:  Introduction to mismatch binding with metallointercalators
2.1.1:  General notes on synthesis
2.1.1.1:  Rhodium coordination complexes
 The synthesis of rhodium(III) coordination complexes is relatively straightforward 
as much work has been done in this field previously.  In general, the desired complexes 
fall into one of two categories: plain intercalators and conjugates.  The intercalators 
by themselves typically employ an intercalating ligand and ancillary ligands to suit 
the purpose.  The ancillary ligands may or may not supply additional functionality for 
DNA binding, but typically they are chosen for their stability and synthetic accessibility.  
Typical ancillary ligands would include 2,2’-bipyridine, 1,10-phenanthroline, or 
ammonia.
 The synthesis of rhodium(III) complexes typically begins with the RhCl3·xH2o 
salt.  This salt is can be readily converted to a variety of metallointercalators containing 
one intercalating ligand, and ancillary ligands.  Ancillary ligands are installed first with 
a hydrazine promoted ligand exchange.  This leads to a cis-dichloro complex which can 
be reacted with triflic acid followed by ammonia to form a cis-diammine complex.  This 
cis-diammine can be used in a quinone condensation reaction to form the desired diimine 
intercalating ligand.
 Many ligand exchange reactions of rhodium(III) are promoted by the inclusion of 
catalytic amounts of hydrazine within the reaction.1  While the reaction with hydrazine is 
not fully understood, it is believed that hydrazine, being a two electron reductant, reduces 
a small amount of rhodium(III) to rhodium(I) which is substitutionally more labile.  The 















Figure 2.1:  Synthesis of rhodium(III) complexes by hydrazine promoted 
ligand exchange.  The addition of hydrazine to the reaction mixture promotes 
a wide variety of ligand exchange reactions of rhodium(III).  This occurs by 
formation of a catalytic amount of rhodium(I) which can exchange ligands more 
readily followed by electron transfer to another rhodium(III) center.  These 
additions proceed in a stepwise fashion from mono to bis to tris.
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to another metal center.  Single electron reductants have been shown to not catalyze 
ligand exchange even those with similar reducing potentials to hydrazine.1  This suggests 
that rhodium(II) is not involved, but it is still possible that it is involved.  Additional 
information has shown that these reactions ligand exchanges proceed in a stepwise 
reaction.2  This is important as it allows for the creation of heteroleptic species in a 
rational manner.
 Exchange of chloride ligands is achieved using trifluoromethanesulfonic acid, 
triflic acid.3; 4  Rhodium complexes can simply be dissolved in neat triflic acid followed 
by precipitation with ether and filtration to recover the complex.  This method is quick, 
~1 hour and efficient, yields are often quantitative, for the removal of chloride ligands 
and replacing them with the weakly coordinating triflate ligand.  This triflate can be 
replaced by virtually any ligand by simply dissolving the complex and ligand in solution.  
The major drawback of this method is that triflic acid is extremely acidic and ligands 
which are labile to acid are obviously incompatible.  One alternative to this procedure 
includes simply boiling the complex in water which will form the labile diaquo complex 
although the reaction times can be exceedingly long, and yields are often not as good as 
the triflate reaction.5  
 The triflate complexes are then replaced with ammonia by introduction of 
concentrated ammonium hydroxide or condensation of anhydrous ammonia gas, using 
a dry ice bath.3; 4  Either of these methods can be employed to form amine complexes 
from the corresponding triflates.  These diamine complexes can then be condensed with a 
quinone to form the desired complexes.
 Three ligand complexes will typically need an additional ligand introduced after 






















trif lic acid nh3
Figure 2.2:  Triflic acid for ligand exchange.  Triflic acid can be used to remove 
chloride ligands from rhodium by simply dissolving the complex in neat triflic 
acid.  These triflate ligands can be easily exchanged for a variety of ligands 
including the cis-diamine desired for o-quinone condensation.
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2.1.1.2:  Quinone condensation
 In rhodium(III) metallointercalators, diimine intercalating ligands are normally 
used.  These intercalating ligands are synthesized by the o-quinone condensation 
method.6  This reaction is based upon the extensive work of Sargeson involving 
intermolecular7 and intramolecular8 condensation reactions.  Schiff base condensations 
have been shown to be possible with coordinated ligands with retention of configuration 
at the metal center.8; 9  These methods can be used to create a variety of bimetallic 
species.10  
Before this method was introduced, these hydrogen imines were typically 
very difficult to access synthetically.  Typically these ligands were synthesized by the 
coordination of a diamine followed by air oxidation to form a diimine.11  This method 
has been employed extensively in the synthesis of phi complexes.  The other alternative 
method is the in situ deprotection of a trimethysilylimine.12  This produces the diimine 
in solution which is subject to rapid decomposition unless it is trapped by coordination 
to the metal center.  This method was employed in the synthesis of [Rh(phi)3]Cl3 and 
[Ru(phi)3]Cl2.  Both of these methods are capable of producing diimine complexes, albeit 
at low yields and under inconvenient anaerobic conditions. 
 In the quinone condensation method, a metal bound cis-diamine is deprotonated 
by a base and attacks the quinone to form a hemiaminal intermediate.8  This intermediate 
can then dehydrate to form the desired metal bound imine.  In its original, form this 
reaction was performed in a mixture of acetonitrile and water with sodium hydroxide as 
the base.6  Reactions proceed rapidly with 9,10-phenanthrene quinone to form the phi 
ligand.  Additionally the sterically hindered chrysi ligand can also be synthesized by this 
method although reaction times are increased.  
 While this system works well for the synthesis of the chrysi ligand, it is not 

























Figure 2.3:  O-quinone condensation.  A cis diammine complex is deprotonated 
by base.  This coordinated amide can then attack the quinone carbon to form a 
hemiaminal intermediate.  This can then dehydrate to form an imine.  This is 
followed by an intramolecular condensation reaction to form the desired diimine 
ligand.
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way, but are susceptible to hydrolysis in the presence of water.  Non-aqueous conditions 
are desired.  Phzi complexes can be synthesized using acetonitrile with a small amount of 
water added to dissolve the sodium hydroxide.  Using this reduced amount of water does 
significantly reduce the decomposition of the quinone and boost the yield of the diimine 
complex.
 Essentially any metal-bound ammine can be used in this reaction with a few 
caveats.  Not all metal-bound ammines have the same pKa.14  Rhodium(III) amines have 
a pKa of ~10 whereas ruthenium(II) amines are much more resistant to deprotonation.  
The pKa of a bound ammine is also strongly affected by the trans ligand.15  In the case of 
[Rh(ppy)2(nh3)2]
+ the ammines require much more basic conditions to be deprotonated 
because of the strongly donating trans carbon donor.  A strong donor trans to an ammine 
also makes the ammine more labile.  This can make a condensation reaction unrealistic 
because the added base will simply replace the bound ammine in some cases.  If a 
strong sterically hindered base is employed, it may be possible to perform quinone 
condensations in these cases.
 It is interesting to note that using a completely water free solvent system is 
possible.  Using acetonitrile as a solvent with triethylamine as a base causes rapid 
production of chrysi.  This is a bit surprising considering that the typical imine formation 
reaction requires the participation of solvent protons.  It is possible that an intramolecular 
proton transfer occurs which can effect the same transition. 
2.1.2:  Assessing the DNA binding properties of metallointercalators
2.1.2.1:  Direct photocleavage
 The simplest method for assessing binding of a metal complex to a particular 
site is UV excited photocleavage.16  Most rhodium diimine complexes are capable 
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of hydrogen atom abstraction from their excited states.17  This direct hydrogen atom 
abstraction occurs without diffusion, marking the site where the complex is bound.  This 
cleavage of the DNA can be analyzed by denaturing polyacrylamide gel electrophoresis, 
separating the DNA based upon molecular weight and charge.  The sites can be 
determined by comparison to the Maxam-Gilbert sequencing reactions.  Cleavage 
intensities can be determined by photography or phosphorimagery.
 Nonspecific complexes, such as [Rh(bpy)(phi)2]Cl3, show cleavage at most 
bases.16    A series of cleavage reactions is performed varying the concentration of the 
metallointercalator with a constant concentration of DNA.  These complexes can be 
characterized by a non-specific DNA binding constant.  This can be determined by the 
quantitation of the parent uncleaved DNA versus the intergrated intensity of the entire 
lane.  This fraction cleaved is plotted versus complex concentration and fit to a sigmoidal 
curve.  The inflection point of the graph can then be used to determine the binding 
constant of the complex
 Specific complexes such a [Rh(bpy)2(chrysi)]Cl3 have one preferred binding 
site and several undesirable sites.18   Experiments can be performed like those for 
nonspecific complexes although nonspecific binding may complicate analysis of binding.  
An alternative method is to hold the ratio of complex to DNA constant and increase 
both simultaneously.  This type of experiment allows the specific binding constant to 
be determined without the complication of nonspecific binding.  Fraction cleaved is 
determined and plotted versus increasing concentration.  The data are plotted and fit to a 
sigmoidal curve.  The inflection point is again used to determine the binding constant via 
a slightly different formula.  Non-specific binding constants are determined in a method 
identical to that for a nonspecific complex.
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2.1.2.2:  Photofootprinting
 If the complex is not proficient at direct photocleavage, binding of the complex 
to DNA can still be assessed by footprinting.  Typically weak binding footprinting agents 
are used for these reactions such as [Fe(EDTA)]2-.  This allows for easy determination of 
binding constants by footprinting.
 Footprinting using strong binding agents is also possible, although it introduces 
another equilibrium into the reaction.  Footprinting using strong binding nonspecific 
complexes can be used for qualitative analysis of binding, but cannot provide a 
quantitative measure of binding unless the specific binding constants for the complex at 
every site in a duplex are determined.  This may be possible for a very short duplex, but 
in general the analysis required would be prohibitive.
 The binding of several complexes has been assessed through these footprinting 
competition experiments.  A regime is chosen where the footprinting complex is 
tightly bound to its DNA.  Then varying concentrations of the competing complex are 
added.  This will cause the footprinting complex to become dissociated from the site 
and the cleavage of the DNA is reduced.  This reduction in cleavage is measured with 
phosphorimagery, graphed and apparent binding constant measured.  This value is then 
used to compute the correct binding constant.  This method cannot lead to an accurate 
determination of the binding constant when the unknown complex is a tighter binder than 
footprinting complex.
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2.2:  [Rh(bpy)2(phzi)]Cl3, a high affinity binder of DNA mismatches
2.2.1:  Introduction
 The targeting of single base mismatches in DNA represents a challenging 
problem in molecular recognition.  The mismatched site may be of variable sequence 
and within a variable sequence context.  What distinguishes such a site is instead the 
local destabilization in opposing bases because of the absence of Watson-Crick hydrogen 
bonding.19  While challenging, however, the development of small molecules targeted 
to mismatches offers many applications. Site-specific mismatch probes could be used in 
discovery efforts to identify single nucleotide polymorphisms.  Moreover, such molecules 
could provide the basis for the development of novel chemotherapeutics.  Many cancers 
are associated with a deficiency in mismatch-repair.20; 21  Hence, by directing small 
molecules to the accumulated mismatches, a cancer-specific targeting strategy could be 
envisioned.
 In our laboratory, we have exploited the local helix destabilization associated 
with mispairing in the design of a metal complex targeted to mismatches.18; 22  Shown 
in figure 2.5 is a rhodium complex containing the benzo[a]phenazine quinone diimine 
(phzi) ligand as well as chrysene quinone diimine (chrysi) and phenanthrene quinone 
diimine (phi) ligands.  Octahedral rhodium(III) complexes containing the phi ligand 
bind avidly to double helical DNA by intercalation23; upon photoactivation, direct 
DNA strand cleavage is also promoted at the bound site.16  By tuning the ancillary 
ligands, complexes can be prepared that are either site specific or sequence neutral.  
[Rh(bpy)phi2]
3+, for example, binds to B-DNA with little site-selectivity16, while 
Adapted from Junicke, H., Hart, J. R., Kisko, J., Glebov, O., Kirsch, I. R. & Barton, J. K. 
(2003). A rhodium(III) complex for high-affinity DNA base-pair mismatch recognition. 





















Figure 2.4:  Bulky metallointercalators.  Shown above is [Rh(bpy)2(phzi)]
3+, below, 
the phi, chrysi, and phzi intercalating ligands.  The phzi ligand is of a similar width 
to the chrysi ligand, but the inclusion of heterocyclic nitrogens increases affinity to 
mismatched DNA.
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[Rh(S,S-dimethyltrien)(phi)]3+ specifically targets the sequence 5’-TGCA-3’.24  The high 
resolution crystal structure of [Rh(S,S-dimethyltrien)(phi)]3+ bound to a DNA octamer 
shows site-specific intercalation by the complex from the major groove side of the helix, 
with site-discrimination determined through an ensemble of hydrogen bonding contacts 
and methyl-methyl interactions.25  The intercalated phi ligand itself resembles another 
base pair, stacked at a distance of 3.4 Å between neighboring base pairs, and with an 
expanse across the ligand of dimensions matching that of the base pairs above and below. 
 The chrysi complex represents our first generation complex targeted to 
mismatches.18 The site specificity of the complex is derived from the fact that it is a 
more bulky intercalator with an expanse exceeding that of the well-matched base pair.  
Owing to shape selection, the complex is unable to bind to well-matched B-form DNA.  
However, at sites where a base pair is destabilized, intercalation of the chrysi complex 
can occur. [Rh(bpy)2chrysi]
3+ has been shown to be both a general and remarkably 
specific mismatch recognition agent.26; 27  Specific DNA cleavage is observed at over 
80% of mismatch sites in all the possible single base pair sequence contexts around the 
mispaired bases.   Moreover, the complex was found to recognize and photocleave at a 
single base mismatch in a 2725 base pair linearized plasmid heteroduplex.
 Here we describe the synthesis and application of a second generation mismatch 
recognition agent, [Rh(bpy)2phzi]
3+. This complex shares with the chrysi complex a 
sterically demanding intercalating ligand.  However, the phzi ligand, as an aromatic 
heterocycle, offers the possibility of greater stabilization through stacking within the 
mismatched site.  Indeed, [Rh(bpy)2phzi]
3+ binds mismatched sites with a binding affinity 
increased by two orders of magnitude without a loss in site-selectivity. This high affinity 
allows the application of the complex in the differential targeting of DNA in a mismatch-
repair deficient cell line.
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2.2.2:  Synthesis and experimental
 Materials. Commercially obtained chemicals were used as received.  Bipyridine, 
triflic acid, 2,3-dichloro-1,4-napthoquinone and phenylenediamine were purchased from 
Aldrich.  RhCl3•2h2O was obtained from Pressure Chemical.
 Instrumentation.  Electronic spectra were recorded on a Beckman DU 7400 
UV-visible spectrophotometer.  Mass spectra (ESI) were measured on an LCQ mass 
spectrometer.  High-performance liquid chromatography was performed on a Waters 996 
system using a Vydac C18 column (4.0 mL/min liquid phase, linear gradient over 50 min 
from 100% 50 mM NH4OAc, pH 7.0 to 100% acetonitrile).  NMR spectra were recorded 
on a Varian Mercury 300 MHz instrument.  DNA synthesis was performed on an ABI 
392 DNA/RNA synthesizer using reagents from Glen Research.  DNA was purified using 
Glen Research Poly-Pak II cartridges followed by reverse phase HPLC.  Photocleavage 
reactions were carried out using a 1000 W Oriel Hg/Xe arc lamp with a monochromator 
fitted with a 300 nm cutoff filter and an IR filter.  
 Synthesis of Benzo[a]phenazinequinone.  This compound has previously 
been synthesized.28  The synthetic procedure used is elaborated here.  The quinone 
is synthesized through an electophilic aromatic substitution followed by an imine 
condensation.  This intermediate is then oxidized by nitric acid to the desired quinone.  
2,3-dichloro-1,4-naphthaquinone (9 g, 40 mmol) and 1,2-phenylenediamine (4 g, 
37 mmol) were dissolved in 200 mL pyridine.  The solution was heated with a boiling 
water bath for 1 hour.  The dark red solution was filtered and the solid was collected.  The 
solid was dissolved in 100 mL of 100 ºC pyridine and filtered again.  The solution was 
cooled to -20 ºC and the zwitterionic intermediate, 6-pyridinium-benzo[a]phenazin-5-
olate, was isolated by filtration.  The collected solid was freed from excess pyridine by 
















Figure 2.5:  Synthesis of phzi quinone.  2,3-dichloro-naphtho-1,4-quinone is reacted 
with o-phenylene diamine in pyridine to produce a zwitterionic species.  This species 
can then be oxidized by nitric acid under acidic conditions to form the desired phzi 
quinone.
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interference if some pyridine remains.  
 The intermediate was oxidized to the desired benzo[a]phenazine-5,6-quinone 
by oxidation with nitric acid.  1 g of the 6-pyridinium-benzo[a]phenazin-5-olate was 
dissolved in 35 mL glacial acetic acid, 4 mL nitric acid, and 2.3 mL of water.  The red 
brown solution was heated to 80 ºC for 1 hour.  The product was precipitated by pouring 
of the solution into 100 mL of cold water.  The precipitate was filtered from solution 
and washed 3 times with ethanol and 3 times with ether to yield a yellow powder with 
a slight green tinge.  1h nmR (cdcl3, 300MHz)  8.78ppm (d, 1H, 7.9Hz), 8.24ppm (d, 
1H, 8.6Hz), 8.21ppm (d, 1H, 10Hz), 8.15ppm (d, 1H, 7.4Hz), 8.01ppm (t, 1H, 6.8Hz), 
7.94ppm (t, 1H, 6.4Hz), 7.90ppm (t, 1H, 7.8Hz), 7.73ppm (t, 1H, 7.6Hz)
 Synthesis and Characterization.  Rac-[Rh(bpy)2phzi]Cl3, (bis(2,2’-bipyri
dine)benzo[a]phenazine diimine rhodium(III) chloride). Rac-[Rh(bpy)2(phzi)]Cl3 
was synthesized using the o-quinone condensation method previously employed in the 
synthesis of [Rh(bpy)2(chrysi)]Cl3.6  [Rh(bpy)2(nh3)2]OTf3 (100 mg, 0.1 mmol) and 
benzo[a]phenazinequinone (35 mg, 0.125 mmol), were prepared according to literature 
procedure.5; 28  These were dissolved in dry acetonitrile (50 mL). Aqueous sodium 
hydroxide (2 mL, 0.2 M) was added and the solution was rapidly stirred for 30 minutes 
at ambient temperature. The reaction was quenched with the addition of 35 mL water 
and 0.2 N HCl to neutralize.  The acetonitrile was removed in vacuo. The remaining 
solution was filtered from the brown solid and loaded on a CM-C25 Sephadex cation 
exchange column (resin equilibrated with 0.05 M MgCl2). A yellow organic ligand passes 
right through. After rinsing with water, 0.05 M MgCl2, a green fraction elutes which 
was collected and concentrated on a Seppac-C18 column and eluted with a mixture of 
acetonitrile/water/TFA (1:1:0.001) and lyophilized to dryness. Yield: 23mg (30% yield). 
Microanalysis found (calc): C 54.8 (55.4), H 3.6 (3.3), N 15.3 (14.8). 1H NMR (d6-




























Figure 2.6:  Synthetic scheme for rac-[Rh(bpy)2(phzi)]
3+ using the condensation 
strategy.  Phzi quinone and [Rh(bpy)2(nh3)2]
3+ are dissolved in dry acetonitrile.  The 
reaction proceeds with the addition of several equivalents of sodium hydroxide to 
produce the desired rhodium complex.  The complex is purified by ion exchange 
chromatography.
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6.1 Hz), 8.60 (t, 2H, 8.5 Hz), 8.54 (d, 1H, 6.1 Hz), 8.47 (t, 2H, 8.5 Hz), 8.32 (d, 1H, 8.5 
Hz), 8.20 (d, 1H, 8.5 Hz), 8.11 (t, 1H, 7.3 Hz), 8.03 (m, 3H), 7.94 (t, 1H, 6.1Hz), 7.84 
(t, 1H, 7.3Hz), 7.75 (m, 3H), 7.69 (d, 1H, 6.1 Hz) ppm. UV/vis (H 2O, pH 5): 245 nm, 
(89,800 m-1cm-1); 304 nm (65,800 M-1cm-1), 314 nm (67,300 M-1cm-1), 343 nm (39,300 
m-1cm-1). ESI-MS(cation) 671(M-2H +) observed, 671 calc.
 DNA Preparation and Photocleavage Experiments.  The oligonucleotides, 5’-
gat gtc ggt cCC ACG ATG GTG ACG GAT TAC C-3’ and 5’-GAG TTG GTA ATC 
cgt cac cat cgt gCG ACC GAC ATC ATG CG-3’, where C denotes the postion of 
the mismatch, were synthesized on an ABI 392 DNA/RNA synthesizer, using standard 
phosphoramidite solid-phase synthesis, and initially purified on Poly-Pak II cartridges 
and further purified by HPLC (98% 100 mM NH4OAc/2% acetonitrile to 70% 100 mM 
nh4OAc/30% acetonitrile over 30 minutes).  The single strands were then 5’ labeled 
with [γ-32P]ATP and T4 polynucleotide kinase.  The labeled strands were further purified 
by gel electrophoresis (20% denaturing polyacrylamide gel), eluted from the gel via 
soaking in TEAA, ethanol precipitated, and annealed in the presence of unlabeled DNA.  
To the labeled 31/41-mer duplex (2 µM in 50 mM NaCl, 10 mM TrisHCl, pH 8.5) was 
added either [Rh(bpy)2phzi]Cl3 or [Rh(bpy)2chrysi]Cl3, and the sample was irradiated.  
After irradiation, all samples were lyophilized, denaturing formamide loading dye was 
added, and the samples were electrophoresed on a 20% polyacrylamide denaturing gel. 
The photocleavage results were quantitated via phosphorimagery (Molecular Dynamics 
Phosphorimager).
2.2.3:  DNA photocleavage of a single base mismatch
As is evident in figure 2.8, photoactivation of [Rh(bpy)2phzi]3+ bound 
to a mismatched site leads to direct strand cleavage.  Upon photoactivation of 
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Figure 2.7:  Photocleavage of mismatched DNA with Rhphzi.  Phosphoimagery 
of 20% polyacrylamide gels shows mismatch-specific cleavage by the rhodium(III) 
complex (a) after DNA photocleavage by 1 μM [Rh(bpy)2chrysi]Cl3 (BC) and 0.1 
to 100 μM [Rh(bpy)2phzi]Cl3 (BZ) on [5’-32P]-labeled CC mismatch-containing, 
indicated by *, 31/41-mer DNA duplex (1 μM). All samples were prepared in 
10 mM Tris pH 8.0, 50 mM NaCl. All irradiations were at 313 nm for 15 min. (b) 
after DNA photocleavage by varying concentration of [Rh(bpy)2chrysi]Cl3 (Bc) and 
[Rh(bpy)2phzi]Cl3 (BZ) as well as at different wavelengths for [Rh(bpy)2phzi]Cl3. It 
is notable, that BC does not cleave the DNA at concentrations up to 100 nM whereas 
BZ already shows a cleavage at 10 nM at the mismatch site.  Lanes labeled AG and 
CT refer to Maxam-Gilbert sequencing reactions. DC refers to the dark control DNA 
sample without irradiation, and LC refers to the light control sample irradiated in the 
absence of metal complex. 
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Figure 2.8:  Binding of Rhphzi to mismatched and matched DNA.  Binding 
isotherms for [Rh(bpy)2phzi]
3+ targeted to a C-C mismatch-containing oligonucleotide 
(closed circles) and the highest affinity well-matched (open circle) site in the same 
duplex.  Photocleavage reactions were performed in 50 mM NaCl, 10 mM Tris·Cl, 
pH 8.5 buffer with irradiation 313 nm radiation for 15 min. The concentration of the 
oligomer varied from 1 × 10-10 to 4 × 10-4 M with the rhodium complex at 10-fold 
lower concentration. Samples were eluted through 20% denaturing polyacrylamide gels 
and the data analyzed using a Molecular Dynamics Phosphorimager and ImageQuant 
software. Cleavage is observed at the base 3’ to the C-C mismatch on the shorter strand. 
For comparison, the specific binding affinity of the corresponding chrysi complex to this 
site is 3.1 × 10-5 m-1.
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[Rh(bpy)2phzi]3+ in the presence of a mismatch-containing DNA duplex, site-specific 
photocleavage is observed at the base 3’ to the mismatch site.  Both the position of 
strand cleavage and the level of specificity are in accordance with that seen using the 
chrysi complex.  Significantly, however, specific cleavage of the mismatch site by 
[Rh(bpy)2phzi]3+ can be seen at metal concentrations as low as 10 nM.
 Titrations as a function of concentration, where the ratio of metal/DNA is kept 
constant, can be used to establish the specific binding constant to an individual site. 
Figure 2.9 shows the quantitation for such a photocleavage titration.  The specific 
binding constant for [Rh(bpy)2phzi]3+ at the C-C mismatch in this oligonucleotide is 
1 × 107 m-1.  This compares to a value of 3 × 105 m-1 for [Rh(bpy)2chrysi]3+ under 
comparable conditions.
Not only does [Rh(bpy)2phzi]3+ bind more tightly to mismatched sites, 
photoactivation experiments reveal also that the complex has approximately a five-fold 
higher photoefficiency than the chrysi analogue in cleaving the C-C mismatch. The 
last three lanes in figure 2.8 also show the photoefficiency for the complex at different 
wavelengths. Remarkably, the cleavage can be seen even at visible wavelengths of 
525 nm.  
Site-specific binding by [Rh(bpy)2phzi]3+ can also be compared quantitatively 
to non-specific binding to well-matched sites on the duplex (figure 2.9).  For this 
oligonucleotide, the highest cleavage intensity other than that for the C-C site is evident 
within the duplex region 5’-GTCGG-3’.  The determination of the binding constant for 
this site yielded a value of 4 × 105 m-1, almost two orders of magnitude weaker than 
that for the mismatch. This represents the highest well-matched site affinity, so that the 
average non-specific affinity is weaker.  This level of specificity is comparable to that 
seen with the chrsyi complex.18 
 [Rh(bpy)2phzi]3+ targets not only the C-C mismatch but other mismatches as 
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well.  The full family of mismatches was examined through photocleavage experiments 
on a 31 base-pair oligomer by varying the base sequence at the central mismatch 
site. The pyrimidine mismatches in particular, including C-T, T-T, and T-C, are also 
readily cleaved.  By quantitative photocleavage titration, the binding affinity for the 
C-A mismatch is found to be 3 × 106 m-1, while that for C-T is 6 × 107 m-1.   Overall, 
targeting appears not to be base specific, but mismatch specific.  As with the parent chrysi 
complex, then, site specificity depends upon the local helix destabilization associated 
with mispairing.  
2.2.4:  Photocleavage efficiency
 Also of interest, while [Rh(bpy)2phzi]3+ has the ability to target a variety of 
different mismatches with high affinity, it is not able to cleave all mismatches with equal 
photoefficiency.  This may determined through quantitative photocleavage titration; at 
maximum binding, different intensities of photocleavage are observed. The different 
photoefficiencies can be understood in terms of variations in bound geometries within 
the different mismatch site, since photocleavage is expected to depend upon access of the 
photoexcited ligand radical to hydrogen atoms on the sugar.16  Several mismatches, such 
as the C-C and T-T, are cleaved with much better efficiency than [Rh(bpy)2(chrysi)]3+; 
others such as C-A are bound tightly but do not exhibit efficient cleavage.  
2.3:  [Rh(bqdi)2(chrysi)]
3+, a binder of G-G DNA mismatches
2.3.1:  Introduction
 While [Rh(bpy)2(phzi)]Cl3 is a higher affinity complex, it retains similar mismatch 
recognition properties to the [Rh(bpy)2(chrysi)]Cl3 complex.  It was desired to synthesize 
a complex which would be able to recognize mismatches which were not recognized 
by the parent complexes.  In general, these mismatches are the guanine containing 
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mismatches G-G, G-A, and G-T.  
 The strategy for the creation of this new complex was simple.  Guanine containing 
mismatches are not stabilizing in comparison to Watson-Crick base pairs, but are simply 
more stable than other mismatches.29  If the affinity of a complex could be boosted 
slightly perhaps it would be possible to target these guanine containing mismatches.
 Previous work within our group has demonstrated the ability of coordinated 
amines in the recognition of guanine bases.  Several complexes have been synthesized 
which demonstrate this increased affinity for guanine rich sites.30  In these complexes, 
amines coordinated in the axial position of a metallointercalator hydrogen bond with the 
O6 of the guanine base. This hydrogen bonding is readily seen in the crystal structure of 
[Rh(dimethyl-trien)(phi)]Cl3.
25 
 The goal then is to add such functionality to one of our mismatch intercalators 
to see if the increase in binding affinity will be sufficient to bind guanine containing 
mismatches.  While this may seem simple enough there are two complicating factors.  
First, the binding of [Rh(bpy)2(chrysi)]Cl3 to DNA has never been adequately described.  
While intercalation from the major groove would seem to be the obvious binding mode, 
there is little evidence for or against this.  Additionally the location of the mismatched 
bases is also very important.  If these bases are in an extrahelical conformation upon 
binding, they will not be available for hydrogen bonding.
 The other complication is the photoefficiency of rhodium amine complexes.  
Upon UV excitation of a rhodium intercalator, a transient species capable of hydrogen 
atom extraction is formed.17  It has been previously shown that when ancillary ligands 
are changed from bipyridine or phenanthroline to amines the yield of photocleavage 
is significantly reduced.  For this reason, the 1,2-benzoquinone diimine, bqdi, ligand 
was also employed.31  This ligand has been shown to not be an intercalator of DNA 
and provides an axial imine moiety which, similar to an amine, should be capable of 
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hydrogen bonding with the O6 of guanine.  Additionally it was believed that these bqdi 
complexes would show a higher photoefficiency for photocleavage as compared to 
ammine complexes.  However these complexes do not show efficient photocleavage, but 
binding to G-G mismatches can still be observed.
2.3.2:  Experimental
 Synthesis of [Rh(NH3)4(chrysi)]Cl3. [Rh(NH3)6]OTf3 was prepared by the 
method of Sargeson as described previously.3  [Rh(NH3)6]OTf3, 100 mg, was reacted with 
39 mg chrysene quinone in 50 mL acetonitrile, 50 mL water with 0.2 mL 1 M sodium 
hydroxide as a catalyst.  Acetonitrile is removed under vacuum followed by filtration, 
which removes the unreacted chrysi quinone.  The desired complex is separated from 
unreacted [Rh(NH3)6]OTf3 by Seppac C18 cartridge and eluted with 1:1:0.001 acetonitrile:
water:TFA. This forms the desired [Rh(NH3)4(chrysi)]OTf3 complex in 65% yield, 85 mg. 
The NMR of this species is complex at room temperature due to slowly interconverting 
hydrogen bonded structures.  At higher temperatures these interconvert more rapidly, for 
this reason NMR data of this complex is taken in DMSO at 50 ºC.  1H NMR (d6-DMSO, 
300 MHz): δ 13.30 (s), 12.32 (s), 8.876 (t, 1H, 7.7Hz), 8.787 (d, 1H, 7.9Hz), 8.57-8.51 
(m,2H), 8.358 (dd, 1H, 8.9Hz, 4.6Hz), 8.145 (d, 1H, 7.7Hz), 7.85-7.70 (m, 4H), 4.73-4.54 
(broad m, 6H), 3.862 (s, 3H), 3.636 (s, 3H) ppm. UV/vis (H 2O, pH 5): 263 nm, (60,900 
m-1cm-1); 283 nm (38,100 M-1cm-1), 326 nm (12,600 M-1cm-1), 413 nm (12,000 M-1cm-
1). MALDI-MS(cation) 425m/z (M-2H  +) observed, 427m/z calc.
 Synthesis of [Rh(bqdi)2(chrysi)]Cl3.  [Rh(NH3)4(chrysi)]OTf3, 25 mg, with 
100 mg 1,2-phenylene diamine in a simple displacement reaction in 100 mL water 
with a crystal of hydrazine hydrochloride as a catalyst.  This solution was allowed to 

















































Figure 2.9:  Synthesis of [Rh(NH3)4(chrysi)]
3+ and [Rh(bqdi)2(chrysi)]
3+.  
[Rh(NH3)6]OTf3 and chrysene quinone are dissolved in a 3:1 acetonitrile:water 
mixture with excess of sodium hydroxide to form [Rh(NH3)4(chrysi)]
3+.  This 
is purified by reverse phase chromatography.  The pure [Rh(NH3)4(chrysi)]
3+ is 
stirred with an excess of o-phenylene diamine in water for 3 days under oxygen 
atomosphere.  The compound is purified from the reaction mixture by ion 
exchange chromatography
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[Rh(pda)2(chrysi)]OTf3 which is not isolated, but upon standing oxidizes with air 
to form the desired [Rh(bqdi)2(chrysi)]OTf3.  The solution is extracted 5 times 
with 20 mL dichloromethane to remove excess ligand.  The resulting solution of 
[Rh(bqdi)2(chrysi)]OTf3 was purified by ion exchange chromatography on Sephadex 
CM-25 resin using 0.1 M MgCl2 as an eluant.  This also exchanges the triflate ions for 
chloride. The eluant is collected onto a SepPac C18 reverse phase cartridge and eluted 
with 1:1:0.001 acetonitrile:water:TFA.  The solution is then dried under vacuum to isolate 
the desired complex. Yield 2.5 mg, 13% yield. UV/vis (H 2O, pH 5): 263 nm, (56,400 
m-1cm-1), 323 nm (14,200 M-1cm-1), 399 nm (12,600 M-1cm-1).  MALDI-MS observed  
573 m/z (M-4H+) calculated 573 m/z.
 DNA Preparation and Photocleavage Experiments [Rh(bqdi)2(chrysi)]
3+.  
The oligonucleotides, 5’-GAT GTC GGT CCC ACG ATG GTG ACG GAT TAC C-3’ 
and 5’-GGT AAT CCG TCA CCA TCG TGC GAC CGA CAT C -3’, where C denotes 
the postion of the mismatch, were synthesized on an ABI 392 DNA/RNA synthesizer, 
using standard phosphoramidite solid-phase synthesis, and initially purified on Poly-
Pak II cartridges and further purified by HPLC (98% 100 mM NH4OAc/2% acetonitrile 
to 70% 100 mM NH4OAc/30% acetonitrile over 30 minutes).  The single strands were 
then 5’ labeled with [γ-32P]ATP and T4 polynucleotide kinase.  The labeled strands were 
further purified by gel electrophoresis (20% denaturing polyacrylamide gel), eluted 
from the gel via soaking in TEAA, ethanol precipitated, and annealed in the presence of 
unlabeled DNA.  To the labeled 31-mer duplex (2 µM in 50 mM NaCl, 10 mM TrisHCl, 
pH 7.0) was added either [Rh(bqdi)2chrysi]Cl3 or [Rh(bpy)2chrysi]Cl3, and the sample 
was irradiated for 15 minutes using a solar simulator.  After irradiation, all samples 
were lyophilized, denaturing formamide loading dye was added, and the samples were 
electrophoresed on a 20% polyacrylamide denaturing gel. The photocleavage results were 
quantitated via phosphorimagery (Molecular Dynamics Phosphorimager).
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 Competition between [Rh(bqdi)2(chrysi)]Cl3 and [Rh(bpy)2(chrysi)]Cl3.  in 
this gel, 5 μL of 5 μM [Rh(bpy)    2(chrysi)]Cl3 and 10 μL of 2.5 μM DNA, sequence is       
the same used in the previous experiment, was added to 5 μL of [Rh(bqdi)  2(chrysi)]Cl3, 
whose concentration varied from 1 μM to 500 μM. This would allow the         
[Rh(bqdi)2(chrysi)]Cl3, which does not cleave, to compete with the [Rh(bpy)2(chrysi)]Cl3, 
which does cleave.  These samples were irradiated by a solar simulator for 15 
minutes.  After this the samples were separated by gel electrophoresis and imaged by 
phosphorimagery.  The data was analyzed as the fraction of DNA cleaved and plotted 
against concentration.  The data was then fitted to a sigmoidal curve with an binding 
constant of 1 × 106 m-1.
 Footprinting the binding of [Rh(bqdi)2(chrysi)]Cl3 to a G-G mismatched 
DNA duplex with [Rh(bpy)2(phi)]Cl3. The experiment was conducted by mixing 1 μM 
DNA duplex, 5’-32pi-GAT GTC GGT CGC ACG ATG GTG ACG GAT TAC C-3’ and 5’-
ggt aat ccg tca cca tcg tgG GAC CGA CAT C -3’, 8 μM [Rh(bpy)2(phi)]Cl3 
and a gradient of [Rh(bqdi)2(chrysi)]Cl3 from 125 μM to 25 nM and in the presence 
of 50 mM NaCl, 10 mM Tris pH 7.0.  These samples were irradiated for 3 minutes.  
The cleaved DNA was analyzed by gel electrophoresis.  The gel was imaged by 
phosphorimagery.  The DNA spots were quantitated by Imagequant and plotted as the 
fraction of spot intensity to the lane intensity (fraction cleaved).  The data were fit to a 
sigmoidal curve with an apparent binding constant of 4 × 105 m-1.  Nonspecific sites are 
also noted, but they are at least an order of magnitude less than the G-G mismatch.
2.3.3:  Mismatch binding by bqdi complexes
 After the initial synthesis of [Rh(bqdi)2(chrysi)]Cl3, its properties with DNA 
where investigated.  A series of experiments were conducted with [Rh(bqdi)2(chrysi)]Cl3 
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and C-C mismatched DNA.  This mismatch being the most destabilizing provides the 
best DNA binding site for the newly synthesized complex to determine photocleavage 
properties.  A broad spectrum source was used for irradiation and upon irradiation for up 
to 3 hours, no cleavage of DNA was seen, an example of the lack of cleavage is shown in 
figure 2.10.  [Rh(bpy)2(chrysi)]Cl3 is shown as example of photocleavage.
 This result can be taken one of two ways.  Either the complex does not bind 
mismatches and therefore does not cleave, or it binds mismatches and has a low 
photoefficiency.  To distinguish between these two possibilities, a competition experiment 
between [Rh(bpy)2(chrysi)]Cl3 and [Rh(bqdi)2(chrysi)]Cl3 was conducted.  To a solution 
containing 5 μM duplex containing a C-C mismatch, 5 μM [Rh(bpy)2(chrysi)]Cl3, 10 mM 
Tris pH 7.0, 50 mM NaCl, varying amounts of [Rh(bqdi)2(chrysi)]Cl3 were added.  This 
experiment, shown in figure 2.11, demonstrates that the bqdi complex is competent 
in binding a C-C mismatch.  From this competition data it is possible to determine the 
binding constant of the added intercalator, in this case [Rh(bqdi)2(chrysi)]Cl3.  The 
binding constant of [Rh(bpy)2(chrysi)]Cl3 for a particular mismatch in the absence of 
[Rh(bqdi)2(chrysi)]Cl3 is easily determined  by a simple titration.  When an additional 
intercalator is added to the system, equilibrium is established between the two 
intercalators.  Using a titration of [Rh(bqdi)2(chrysi)]Cl3 against a constant amount 
of  [Rh(bpy)2(chrysi)]Cl3, it is possible to determine the affinity of the new intercalator 
towards a particular site, in this case a C-C mismatch.  This relative measurement along 
with the absolute binding affinity of [Rh(bpy)2(chrysi)]Cl3 for the particular site can be 
used to calculate the binding affinity of the intercalator.  From this competition data, 
a binding constant to the C-C mismatch of 7 × 105 m-1 can be calculated.  From these 
results, we must infer that the bqdi complex can bind to mismatches, but has a low 
photoefficiency for DNA photocleavage.
 Finally, an experiment was conducted with this complex to determine if 
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Figure 2.10:  Photocleavage with [Rh(bqdi)2(chrysi)]
3+.  Photocleavage 
experiment with a C-C mismatched DNA duplex in the presence of 50 mM 
NaCl and 10 mM Tris pH 7.0.  The mismatch site is indicated by the star.  No 
photocleavage is noted, variation of irradiation time does not produce cleavage.
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Figure 2.11:  Competition between [Rh(bqdi)2(chrysi)]
3+ and 
[Rh(bpy)2(chrysi)]
3+.  Increasing amounts of the bqdi complex are added to 5μM 
DNA containing a C-C mismatch, 5’-32pi-GAT GTC GGT CCc acg atg gtg 
ACG GAT TAC C-3’ and the unlabeled complement with indicated C mismatched 
with a C, at the indicated site with 5 μM [Rh(bpy)2(chrysi)]
3+ in 50 mM NaCl, 10 
mM Tris pH 7.0.  The bqdi complex effectively competes for the C-C mismatch 
site to which the bpy complex is bound.  A binding constant of 1 x 106 m-1 can be 
calculated from the fit of this data.
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indeed it could bind a G-G mismatch.  Because [Rh(bpy)2(chrysi)]Cl3 does not bind 
G-G mismatches it cannot be used.  Binding sites of non-photoreactive major groove 
intercalators can be determined by footprinting using the non-specific [Rh(bpy)2(phi)]Cl3.  
This complex cleaves DNA by abstracting a hydrogen atom from the DNA backbone 
upon UV excitation.  Upon the addition of another intercalator, [Rh(bpy)2(phi)]Cl3 can be 
displaced from DNA duplex reducing the damage at a particular site on the DNA.  This 
reduction in damage is called a footprint and it indicates the presence of a competing 
species at that site.  This complex is capable of binding both matched and mismatched 
base pairs within DNA, with little sequence specificity. 
 Using [Rh(bpy)2(phi)]Cl3 as a footprinting agent, The binding of the bqdi complex 
to a G-G mismatch can be assessed.  Solutions containing 1 μM G-G mismatched DNA 
duplex, 8 μM [Rh(bpy)2(phi)]Cl3, 10 mM Tris pH 7.0, and 50 mM NaCl.  To this mixture 
various amounts of [Rh(bqdi)2(chrysi)]Cl3 were introduced before irradiation.  These 
experiments clearly show a footprint at the G-G mismatch site.  At higher concentrations 
the complex effectively blocks all sites on the DNA.  While quantitative measurements of 
binding affinity cannot be obtained from this data, the binding constant of this complex 
to a G-G mismatch is at least 4 × 105 m-1.  Additionally, the binding constant at the G-G 
mismatch is at least 10 times higher than that for the matched base pairs.
 This complex represents the first attempt at the recognition of highly stabilizing 
mismatch.  This mismatch G-G in this sequence context, 5’-CGC-3’ is stabilizing to the 
DNA duplex by -1.22 kcal/mol, as calculated using the nearest neighbor method.29  it 
seems likely that this complex is capable of recognizing other highly stable mismatches.  
Additional studies will be required to determine which mismatches and in what sequence 
contexts this complex will bind.
 How is this complex able to recognize this stable mismatch?  The 
[Rh(bpy)2(chrysi)]
3+ has been shown to bind mismatches if they are destabilized to a 
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Figure 2.12:  Photofootprinting of [Rh(bqdi)2(chrysi)]
3+ binding to a G-G 
mismatch.  Since [Rh(bqdi)2(chrysi)]
3+ is not capable of photocleavage, 
photofootprinting was used as an alternative.  1 μM DNA containing a G-G 
mismatch, 5’-32pi-GAT GTC GGT CGC ACG ATG GTG ACG GAT TAC C-3’ and 
the unlabeled complement with indicated G mismatched with a G, was mixed with 
8 uM [Rh(bpy)2(phi)]
3+ and photocleaved in the presence of varying concentrations 
of [Rh(bqdi)2(chrysi)]
3+, as indicated on the gel.  The reaction was performed with 
50 mM NaCl and 10 mM Tris·Cl as buffer.  The location of the G-G mismatch is 
indicated by the arrow.  Both specific and nonspecific behaviors are noted.
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Figure 2.13:  Binding of [Rh(bqdi)2(chrysi)]
3+ to a G-G mismatch.  The quantified 
intensity of the G-G mismatched site, from figure 2.12, expressed as fraction cleaved, 
is plotted against [Rh(bqdi)2(chrysi)]
3+ concentration.  The apparant binding constant is 
4 × 105 m-1.  The actual binding constant will be this value or higher.  The nonspecific 
binding constant is at least an order of magnitude less.  1μM DNA containing a G-G 
mismatch, 5’-32pi-GAT GTC GGT CGC ACG ATG GTG ACG GAT TAC C-3’ and 
the unlabeled complement with indicated G mismatched with a G, was mixed with 
8 μM [Rh(bpy)2(phi)]
3+ and photocleaved in the presence of varying concentrations 
of [Rh(bqdi)2(chrysi)]
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Figure 2.14:  Two schematic representations of [Rh(bqdi)2(chrysi)]
#+ binding.  it 
seems likely that the chrysi ligand intercalates into the DNA base stack.  This will 
allow the imines of the bqdi ligand to hydrogen bond with the guanine bases present.  
Two modes of intercalation can be proposed.  On the left, the complex inserts in a 
canted mode, stacking with both guanines, and hydrogen bonding with both.  This 
will distrupt the hydrogen bonding of the G-G mismatch and would likely severly 
kink the DNA.  On the right, the complex inserts in a normal intercalative mode, 
stacking with the G-G mismatch and hydrogen bonding with it and nearby G-C base 
pair.
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certain amount.27  It would seem then that this complex has increased affinity to this 
particular site.  This small increase in affinity may be sufficient to push the complex over 
the energetic barrier to a tighter bound form.  
 The structure of how the chrysi ligand binds to the mismatch is also of 
considerable interest.  One possibility is that the axial imines hydrogen bond with the 
O6 of guanine similar to the parent ammine complexes.24; 25; 30  in this case, the chrysi 
ligand intercalates and stacks with both the G-G mismatch and a C-G base pair, hydrogen 
bonding with the guanines of both the mismatch and the matched base pair.  The other 
possibilities are that the chrysi ligand intercalates in a canted fashion with the two 
guanines of the mismatch on opposite sides of the intercalated chrysi ligand.  In this 
situation it would seem that this binding mode would place a severe kink within the DNA 
and hydrogen bonding between the guanines would be lost, but a hydrogen bond from 
the coordinated imine to both of the guanines would be possible.  It seems unlikely that 
extrahelical bases could be involved as the both hydrogen bonding and aromatic stacking 
of the guanine mismatch would both be disrupted and could hardly be recovered by the 
intercalation of the complex.  Minor groove binding also seems unlikely as the complex, 
though smaller, would still seem to be far too large to associate with any depth in the 
minor groove.  Perhaps future studies will elucidate the structure of the intercalated 
chrysi ligand.
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Chapter 3:  Single Nucleotide Polymorphism Discovery by 
Targeted DNA Photocleavage
3.1:  Introduction
 Single nucleotide polymorphisms (SNPs) have been the focus of research for 
both their roles in disease1 and use as markers in genetics2.  Occuring as frequently as 
1 SNP per 1000 base pairs, they are by far the most common mutation present in the 
human genome3,4.  It is estimated that there are 10 million SNPs with an allele frequency 
greater than 1%5 and approximately 5 million so called common SNPs with frequencies 
exceeding 10%6.  Most SNPs have no effect on gene expression or gene products and 
therefore appear to be phenotypically silent.
 It has been suggested that developing a dense map of SNP locations can 
significantly aid in the identification of genetic factors associated with disease7.  Owing to 
the presence of recombination hot spots8,9, the genome is organized into haplotype blocks 
that infrequently undergo recombination separated by areas of frequent recombination.  
On which regions might SNP discovery efforts be focused? Because of the great cost 
associated with full scale mapping of SNPs throughout the genome, current efforts have 
been directed toward SNP discovery within genes likely associated with disease or 
disease predisposition10.  This strategy then necessarily excludes discovery within regions 
of the genome of unknown function.
 Although many have touted the benefits of SNPs, it is because discovering the 
location of low frequency SNPs remains a costly and time consuming challenge that 
Adapted from Hart, J. R., Johnson, M. D., Barton, J. K. (2004). Single-nucleotide 
polymorphism discovery by targeted DNA photocleavage. Proc. Natl. Acad. Sci. USA 
101, 14040-14044.
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SNP discovery efforts have been restricted.  Currently, there are few alternatives to 
resequencing for the initial discovery of these SNPs.  Resequencing is expensive in 
terms of materials, labor, and information processing.11,12  A relatively large population 
must be sequenced throughout the genome7, or alternatively every haplotype block 
and intervening hotspots3, in order to create a high density SNP map of the genome.  
Sequence data from each individual, or pool, must be compared to all other individuals, 
or pools, to detect the presence of a SNP within that sequence.  Current techniques 
require the sequencing of a particular region of the genome several times in order to 
locate a rare Snp11,12.  Additionally these methods suffer from a high false positive rate of 
10%-15%.  Once the SNP has been localized, many existing technologies can be applied 
to determine alleles and allele frequency of the SNP for a broader population13.  For this 
reason the development of a new assay for the discovery and localization of SNPs would 
be particularly attractive. 
 As an alternative to resequencing as a method of SNP discovery, we have adapted 
our mismatch-specific rhodium(III) metallointercalators14,15 to the task of detecting low 
frequency sequence variations.  While DNA mismatches may be of varied sequence 
and within varied sequence contexts, the factor that distinguishes mispaired DNA bases 
from Watson-Crick base pairs is the local instability arising from decreased hydrogen 
bonding and aromatic stacking of the mismatched bases.16  This destabilization is 
exploited in site recognition by [Rh(bpy)2(phzi)]Cl3 (phzi = 3,4-benzo[a]phenazine 
quinone diimine) and [Rh(bpy)2(chrysi)]Cl3 (chrysi = 9,10-chrysene quinone diimine). 
The phi (phenanthrenequinone) ligand is an optimal size for intercalation in well matched 
DNA interbase pair sites, based upon crystallography.16a However, the analogous but 
more bulky phzi and chrysi ligands are wider than a well matched base pair.  This 
shape selective approach allows intercalation of the bulky chrysi and phzi complexes 
in the destabilized region of the DNA mismatch, but not within stable well paired 
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regions.  Rh(bpy)2(chrysi)3+ (Rhchrysi) and Rh(bpy)2(phzi)3+ (Rhphzi) have been 
shown to be remarkably specific and high affinity binders of DNA mismatches.  Upon 
irradiation, these complexes promote direct strand cleavage of the DNA backbone 
selectively neighboring the mismatched site.  It has been documented that Rhchrysi 
targets 80% of all possible base mismatches, with full variation of the sequence 
context as well as identity of the mismatch, and the sites targeted correlate closely with 
their thermodynamic instability17.  Importantly, owing to the high specificity of these 
complexes, the targeting of  a single base mismatch within a 2725 bp DNA duplex by 
photocleavage has also been demonstrated18.
 We have exploited our mismatch-specific rhodium complexes to develop a new 
methodology for the detection of SNPs within genomic DNA, figure 3.1.  The area of the 
genome to be probed for SNPs is amplified by PCR from pooled genomic DNA.  SNPs in 
the PCR product are turned into mismatches by denaturing and annealing the DNA.  The 
site-specific targeting of DNA mismatches by the metal complexes provides a method for 
cleaving the DNA and therefore marking the SNP site.  The SNPs can then be detected 
using capillary gel electrophoresis. 
Resequencing does however have some advantages over our method, specifically 
resequencing gives a clear picture of the alleles present and their frequencies, albeit 
approximately, in addition to the SNPs location.  Regardless of the method of initial SNP 
discovery, larger populations could be more economically genotyped after the initial 
localization of the SNP to give a clearer picture of SNP frequency and distribution within 
a larger and more diverse population.
 In contrast to the resequencing method, our new assay allows for low frequency 
SNPs to be detected directly and unambiguously from a pooled sample, greatly reducing 
the costs for the localization of new SNPs.  Specifically fewer PCR reactions and no 
cycle sequencing is required.  Additionally, information processing is greatly reduced as 
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Figure 3.1:  Strategy for detecting an SNP from genomic DNA in pooled samples.  
The portion of genomic DNA to be analyzed is selected and amplified by PCR.  These 
PCR products are denatured and annealed to produce mismatches at the locations of 
heterozygous SNPs.  The DNA is restricted to create a 3’ underhang to be labeled.  The 
mismatched DNA is then treated with either Rhchrysi or Rhphzi and irradiated to cleave 
the DNA at the locations of the mismatches, corresponding to the SNP sites.  The cleaved 


















individual samples need not be compared to determine the presence of an SNP.
3.2:  Materials and experimental
 Materials. [Rh(bpy)2(phzi)]Cl3 and [Rh(bpy)2(chrysi)]Cl3 were synthesized 
according to published procedures.14,15  Restriction enzymes, EcoRI, XhoI, and ClaI, calf 
intestinal alkaline phosphatase(CIAP), and Taq DNA polymerase were purchased from 
Roche Molecular Biochemicals.  The SNaPshot labeling kit was provided by Applied 
Biosystems.  Primers used were synthesized using an ABI 394 DNA synthesizer by 
standard phophoramidite chemistry and purified using Glen Research PolyPakII columns. 
Plasmids used as templates in this assay were provided by Applied Biosystems.  Pooled 
human genomic DNA was purchased from Roche Molecular Biochemicals.
 Preparation of mismatched templates.  Both the plasmid templates and pooled 
human genomic DNA were amplified using PCR with the primers, F 5’-TTT TTT ATC 
GAT CGC GTT GGC CGA TTC ATT AAT G-3’ and R 5’-TTT TTT CTC GAG GCT 
GCG CAA CTG TTG GGA AG-3’, or F 5’-AAA ATC GAT AGA ACA AAA GGA 
TAA GGG CTC AG-3’ and  R 5’-AAA CTC GAG GTG TGG CCA TAT CTT CTT 
AAA CG-3’ respectively.  These products were sequenced by standard fluorescent dye 
terminator cycle sequencing, shown in figure 3.2 and figure 3.3.  After the amplification 
of the DNA, Primers and unincorporated dNTPs were degraded using a combination 
of 6 U ExoI and 20 U CIAP.  The DNA product was purified using a QIAquick PCR 
purification column eluting into 10 mM Tris HCl buffer, pH 8.0.  DNA was thermally 
denatured under these low ionic strength conditions by heating at 99 ºC for 25 minutes.  
DNA was annealed in the presence of 60 mM Tris HCl pH 7.5, 10 mM MgCl2, 100 mM 
NaCl, 1 mM dithioerythritol, by heating to 95 ºC for 10 minutes and linearly ramping 
temperature to 4 ºC over a period of 150 minutes.   This generates mismatches at 
heterozygous SNP sites.  Restriction sites present in the primers were cut using 5 U ClaI 
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Figure 3.2:  Sequence of PCR product generated from plasmids.  The full product 
is 459 bases in length, restricted product is 440 bases in length.  The polymorphic site 
denoted N in the sequence can be A, T, G, or C, that designation corresponding to the 
base on the forward strand.
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Figure 3.3:  Sequence of PCR product from TNF gene.  Full product is 395 base pairs, 
the -862 SNP is located at position 281.  After restriction the duplex is 382 base pairs in 
length.
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and 5 U XhoI incubated at 37 ºC for 60 minutes.  
 Detection of mismatches generated at the polymorphic sites.  the 
annealed, mismatched DNA was cleaved using 500 nM Rhchrysi or 200 nM Rhphzi, 
in the presence of 30 mM Tris HCl pH 7.5, 5 mM MgCl2, 50 mM NaCl, 0.5 mM 
dithioerythritol, by irradiating samples with 442 nm or 340 nm light, respectively, with 
a 1000 W Oriel Hg/Xe arc lamp fitted with a monochromator, a 295 nm UV cutoff 
filter, and an IR filter (Thermo-Oriel).  Cleavage can also be induced using a standard 
302 nm transilluminator, inverted at a distance of 4 cm from the top of the sample or 
365 nm “blacklight” also a distance of 4 cm. Irradiation times using a transilluminator 
or blacklight are approximately 60 times longer than those required for the arc lamp.  
Following cleavage samples were dried and fluorescent tags were introduced by single 
base extension using the SNaPshot kit.  The fluorescently labeled products were analyzed 
by capillary electrophoresis performed on an ABI 310 Prism instrument using a 47 cm x 
50 μm capillary, POP4 polymer, dye set E5 with LIZ size standards.
3.3:  Preparation of mismatched DNA templates for SNP detection
 Typically, rhodium-mediated cleavage of DNA has been performed on relatively 
short oligonucleotide duplexes and the cleavage products have been monitored using 
denaturing polyacrylamide gel electrophoresis19.  Additionally, duplexes containing 
mismatches have been generated by the high temperature annealing of synthetic single 
stranded dna14.  These conditions provide superb control and sensitivity over reaction 
conditions allowing the determination of binding constants, etc.  In contrast, for the 
detection of SNPs within longer biologically derived DNA duplexes, these methods are 
not applicable.
 As an alternative, DNA duplexes are generated by PCR using a polymorphic 
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template.  These duplexes are then fully denatured at high temperatures and low ionic 
strength to generate single stranded DNA20.  These single strands are then annealed at a 
higher ionic strength by slow cooling to ambient temperature.  In this way, the forward 
and reverse strands anneal randomly so as to obtain a mixture of products, in which DNA 
mismatches are generated at the sites of SNPs.  The degree of strand exchange can be 
calculated from the maximum cleavage intensities observed for equimolar polymorphic 
templates.  In this system, strand exchange exceeds 45%, and approaches the statistical 
limit.  We have chosen to use this low ionic strength method for denaturation over the 
previously demonstrated sodium hydroxide denaturing method18 to eliminate the time 
consuming desalting steps. 
 In addition to the creation of mismatched templates for SNP cleavage, a method 
of detecting the DNA and its cleaved products was needed.  Radionucleotides and 
phosphorimagery were used previously.14,15,18  Fluorescent tagging is preferable because 
of the abundance of instruments available for the rapid and high throughput analysis 
of fluorescently labeled polynucleotides, primarily for sequencing.  To incorporate 
fluorescent tags site specifically, PCR primers used in amplification were tagged with 
a ClaI restriction site on the forward primer and an XhoI restriction site on the reverse 
primer.  After cleavage with the restriction enzymes, these restriction sites may be labeled 
by polymerase and standard dideoxyribonucleotide dye-terminators used in sequencing 
and primer extension genotyping.20 This results in unique fluorescent tagging of both 3’ 
ends of the DNA simultaneously.
 Templates for these studies were derived from two sources.  First for basic 
characterization of the system, a set of four plasmid templates containing a single base 
substitution in their insert was used.  Secondly, a pooled human DNA source from 80 
individuals was used as a template in the detection of a known SNP in the tumor necrosis 
factor (TNF) gene.
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xxGG + CCGC + CG
xxTG + CATA + CG
xxTC + GATA + GC
AG + CTAT + CG
xxAC + GTAT + GC













aThe base pair(s) at the polymorphic site present in the template plasmid.  The first 
base indicates the template plasmid used.  bUpon denaturing and annealing of the PCR 
amplified template, mismatches can be generated as indicated if heterozygousity exists.  
DNA duplexes are denatured in the presence of 10 mM Tris pH 8.5, and annealed with 
the addition of buffer to make a final concentration of 60 mM Tris HCl pH 7.5, 10 mM 
MgCl2, 100 mM NaCl, 1 mM dithioerythritol.  This buffer is diluted to half with the 
addition of metal complex to 500 nM Rhchrysi or 200 nM Rhphzi.  Both cRhphzi and 
dRhchrysi generate site specific cleavage products, upon irradiation at 340 nm for 1 hr or 
442 nm for 1 hr respectively, as denoted by X. 
Table 3.1:  Homozygous and heterozygous templates and their photocleavage
85
3.4:  Discovery of SNPs by photocleavage
 Photocleavage and analysis using the various plasmid templates were performed 
and representative results are shown in figure 3.2.  For plasmid samples not containing a 
heterozygous locus, no cleaved products are detected, figure 3.3.  Irrespective of rhodium 
addition or time of irradiation, a low background is detected in all samples, typically 
present with an intensity of <2% of the parent peak.  In contrast, samples containing 
a heterozygous locus, formed by the mixing of dissimilar templates before annealing, 
clearly show the formation of cleaved products after irradiation.  Within the sequence 
context of our plasmid, the forward strand is preferentially cleaved in all cases.  The size 
of the cleaved product aligns perfectly with the location of the polymorphic site.  Upon 
extensive irradiation, small amounts of cleaved reverse strand are also noted.  This is 
expected as rhodium complexes of this type cleave the DNA duplex asymmetrically18.
 A summary of the possible polymorphisms and their detected cleavage with 
both Rhchrysi and Rhphzi is shown in table 3.1.  As is evident, a variety of SNPs are 
detected using both complexes. Also noteworthy, however, is the lack of reaction with 
the generated AAA site, consistent with previous studies of Rhchrysi targeting as a 
function of sequence context.  Within this sequence context, because of base slippage, 
the adenine-containing mismatches are exceptionally stable, with hydrogen bonding of 
the mismatched adenine base with the thymines present on the opposite strand; thus the 
stabilized site is not targeted.  These data emphasize the fact that specific cleavage is a 
clear indicator of the SNP, but the lack of reaction does not preclude the presence of an 
SNP creating a thermodynamically stable mismatch.
3.5:  Photolysis with common light sources
 A mercury-xenon arc lamp and monochromator are typically employed in our 
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Figure 3.4:  Representative capillary electrophoresis traces demonstrating the 
detection of an SNP within a plasmid.  The red trace represents the forward strand 
while the black corresponds to the reverse strand.  (a) When a homozygous template, 
in this case the homozygous plasmid A, is tested by the assay procedure, no cleaved 
products are detected.  The full length PCR product is present, 436 bases in length.  (b) 
When two templates, here G and C plasmids, are mixed, denatured, and reannealed to 
generate a heterozygous site, mismatches are generated.  After photocleavage for 30 
min at 442 nm with 500 nM Rhchrysi, and fluorescently tagging, the cleaved product, 
170 bases in length, is evident (see experimental section).  The horizontal scale shows 
the fragment size in units of nucleotides.  The vertical scale is fluorescent signal intensity 
in arbitrary units.  We ascribe the small peak ~380 bases in length to overloading of the 
sample.
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photocleavage reactions.  While this lamp is convenient because of its high intensity 
light, other more common laboratory light sources may be utilized in the photocleavage 
reaction.  Both a 302 nm transilluminator used in the visualization of agarose gels, and 
a 365 nm “blacklight” have been used to activate the metal complex for DNA cleavage, 
although at a somewhat diminished rate owing to the decreased intensity of these sources. 
For example, while the arc lamp is capable of driving the cleavage reaction to completion 
in 20 minutes, the 365 nm blacklight can only cleave 28% in 4 hours and the 302 nm 
transilluminator can cleave 15% in 4 hours.  Before any light source is used with this 
assay, controls are conducted in the absence of rhodium complex to determine if the light 
alone can damage the DNA.  None of these lamps are capable of detectably damaging 
DNA. Typical white fluorescent light and incandescent light do not produce sufficient 
ultraviolet light to produce significant strand scission.  
3.6:  Detection of an SNP from a biological source
 Ultimately this method is not designed for the detection of an SNP present in 
a synthetic plasmid, but rather it is designed for the discovery of previously unknown 
SNPs from biological sources.  We therefore sought to examine a target SNP known to 
be present in the general population and well characterized as to its allele frequency as 
a test of the methodology.  Here then, the known SNP, -307, in the TNF promoter22 was 
targeted for detection.
 To determine the presence and frequency of this SNP within our pooled genomic 
DNA sample, this SNP was detected by the generally accepted resequencing method, 
figure 5a.  This shows demonstrates the presence of the -307 SNP within our genomic 
sample.  The frequency of this SNP within the pooled sample is 11% A with the 
remaining 89% C.  
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Figure 3.5:  The discovery of an SNP in the TNF promoter region by two methods, 
(a) resequencing and (b) photocleavage with Rhchrysi.  In (a) The TNF promoter was 
sequenced using a pooled genomic DNA sample.  A portion of this sequencing data is 
shown highlighting a polymorphic site, demonstrating C allele frequency of 89% with 
a minor A allele frequency of 11%.  In (b) using our targeting assay, this SNP is readily 
detected by capillary electrophoresis.  After photocleavage with 500 nM Rhchrysi at 
442 nm for 10 min, the parent band, 377 bases in length, is cleaved and a new peak 
appears at 105 bases.  This fragment length corresponds exactly with the location of the 
SNP detected by sequencing in (a).
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 A pooled DNA sample, taken from a mix of genomic DNA from 80 individuals, 
was amplified using PCR primers designed to target the region of the SNP in the TNF 
promoter. After amplification, the DNA was treated under the same conditions as the 
plasmid derived DNA (vide supra).  Following denaturation and annealing, the 375 
length PCR fragments, incubation with  500 nM Rhchrysi, photolysis, and fluorescent 
tagging, the samples were analyzed by capillary electrophoresis.  As is evident in figure 
5b, a peak appears with a length corresponding precisely to the location of the SNP. The 
contrast in ease of discovery of this SNP using sequencing versus our SNP photocleavage 
methodology is noteworthy.
3.7:  Sensitivity and generality
 The effect of varying the allele frequency was also examined.  Rather than mixing 
approximately equal amounts of two alleles, various fractions of the two alleles were 
mixed and assayed to simulate allele frequencies from 0.01 to 0.99.  In this way the 
sensitivity of this method is measured.  Frequencies as low as 5% are detectable above 
the background present, figure 3.4.
 The sensitivity of this method is ultimately determined by the presence of 
background peaks.  These peaks are present regardless of rhodium complexes or UV 
irradiation.  Therefore this background has been tentatively assigned to PCR pause sites.  
If this background can be reduced, the sensitivity of the method can be enhanced still 
further.
 Utilizing a general mismatch recognition complex should in theory allow for 
any SNP to be detected.  In practice, however, neither Rhchrysi nor Rhphzi are able to 
detect all mismatches.  Both complexes recognize mismatches because of their local 
destabilization within the DNA duplex.  Thus in our assay, SNPs that lead to a stable 
90
Figure 3.6:  A plot showing the effect of varying the allele frequency on the 
fluorescent intensity of the cleaved products.  The fraction of G template added to 
C template was varied over a range of 0.01 to 0.99 to imitate the effect of varying the 
allele frequencies on this assay.  This fraction of G, which may be thought of as an allele 
frequency, is plotted on the horizontal axis.  The normalized fluorescence intensity of 
the cleaved peak is plotted in red.  The normalized background peak intensity is plotted 
in black.  All fluorescence measurements are normalized to the uncleaved parent peak 
intensity.  For fractions of 0.05 or greater, the cleaved peak exceeds background and can 
therefore be detected as an SNP.  A line consistent with a fit to the statistical mixture is 
included to guide the eye.


























mismatch are not detected.  In general, this is not a significant problem, since in a 
statistical mixture, two different mismatches are formed from any SNP.  One tends to be 
a particularly destabilized mismatch while the other is much less so.  For example, G→
C SNP will produce both a stable G-G mispair and a destabilized C-C mispair.  While 
our complexes are not able to detect a G-G mispair, the C-C mispair is easily recognized 
and cleaved.  Nonetheless, illustrated here is an alternate example where photocleavage 
is not noted.  In the case of the A/C heterozygote neither mismatch generated is cleaved.  
The sequence surrounding the mismatch is 5’-AXA-3’/3’-TYT-5’.  Here photocleavage is 
not observed owing to slippage and site stabilization.  Specific photocleavage by the Rh 
intercalator therefore does indeed provide an unambiguous determination of the presence 
of a SNP.  However, the lack of reaction does not establish the absence of an SNP.  This 
assay is then expected to yield the rapid discovery of SNPs across the genome without 
the complication of false positives.
3.8:  References
1. Erichsen, H. C., Chanock, S. J. (2004). SNPs in cancer research and treatment.      Br. 
J. Cancer 90, 747-751.
2. Vignal, A., Milan, D., SanCristobal, M., Eggen, A. (2002). A review on SNP and 
other types of molecular markers and their use in animal genetics. Genet. Sel. 
Evol. 34, 275-305.
3. Carlson, C. S., Eberle, M. A., Rieder, M. J., Smith, J. D., Kruglyak, L., Nickerson, 
D. A. (2003). Additional SNPs and linkage-disequilibrium analyses are necessary       
for whole-genome association studies in humans. Nat. Genet. 33, 518-521.
4. Cooper, D. N., Smith, B. A., Cooke, H. J., Niemann, S., Schmidtke, J. (1985). An 
92
estimate of unique DNA sequence heterozygosity in the human genome. Hum. 
Genet. 69, 201-205.
5. Botstein, D., Risch, N. (2003). Discovering genotypes underlying human 
phenotypes: past successes for mendelian disease, future approaches for complex 
disease. Nat. Genet. 33 Suppl, 228-237.
6. Kruglyak, L., Nickerson, D. A. (2001). Variation is the spice of life. Nat. Genet. 
27, 234-236.
7. Kruglyak, L. (1999). Prospects for whole-genome linkage disequilibrium mapping 
of common disease genes. Nat. Genet. 22, 139-144.
8. Patil, N., Berno, A. J., Hinds, D. A., Barrett, W. A., Doshi, J. M., Hacker, C. R., 
Kautzer, C. R., Lee, D. H., Marjoribanks, C., McDonough, D. P., Nguyen, B. T., 
Norris, M. C., Sheehan, J. B., Shen, N., Stern, D., Stokowski, R. P., Thomas, D. J., 
Trulson, M. O., Vyas, K. R., Frazer, K. A., Fodor, S. P., Cox, D. R. (2001). Blocks 
of limited haplotype diversity revealed by high-resolution scanning of human 
chromosome 21. Science 294, 1719-1723.
9. Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, 
B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., Liu-Cordero, S. N., 
Rotimi, C., Adeyemo, A., Cooper, R., Ward, R., Lander, E. S., Daly, M. J., 
Altshuler, D. (2002). The structure of haplotype blocks in the human genome. 
Science 296, 2225-2229.
10. Martin, A. M., Athanasiadis, G., Greshock, J. D., Fisher, J., Lux, M. P., Calzone, 
K., Rebbeck, T. R., Weber, B. L. (2003). Population frequencies of single 
nucleotide polymorphisms (SNPs) in immuno-modulatory genes. Hum. Hered. 
55, 171-178.
11. Kwok, P. Y., Deng, Q., Zakeri, H., Taylor, S. L., Nickerson, D. A. (1996). 
Increasing the information content of STS-based genome maps: identifying 
93
polymorphisms in mapped STSs. Genomics 31, 123-126.
12. Taillon-Miller, P., Piernot, E. E., Kwok, P. Y. (1999). Efficient approach to unique    
single-nucleotide polymorphism discovery. Genome. Res. 9, 499-505.
13. Kwok, P. Y., Carlson, C., Yager, T. D., Ankener, W., Nickerson, D. A. (1994). 
Comparative analysis of human DNA variations by fluorescence-based 
sequencing of PCR products. Genomics 23, 138-144.
14. Jackson, B. A., Barton, J. K. (1997). Recognition of DNA base mismatches by a 
rhodium intercalator. J. Am. Chem. Soc. 119, 12986-12987.
15. Junicke, H., Hart, J. R., Kisko, J., Glebov, O., Kirsch, I. R., Barton, J. K. (2003). 
A rhodium(III) complex for high-affinity DNA base-pair mismatch recognition. 
Proc. Natl. Acad. Sci. USA 100, 3737-3742.
16. Peyret, N., Seneviratne, P. A., Allawi, H. T., SantaLucia, J. (1999). Nearest-
neighbor thermodynamics and NMR of DNA sequences with internal A-A, C-C, 
G-G, and T-T mismatches. Biochemistry 38, 3468-3477.
17. Kielkopf, C. L., Erkkila, K. E., Hudson, B. P., Barton, J. K., Rees, D. C. (2000). 
Structure of a photoactive rhodium complex intercalated into DNA. Nat. Struct. 
Biol. 7, 117-121.
18. Jackson, B. A., Barton, J. K. (2000). Recognition of base mismatches in DNA by 
5,6-chrysenequinone diimine complexes of rhodium(III): a proposed mechanism 
for preferential binding in destabilized regions of the double helix. Biochemistry 
39, 6176-6182.
19. Jackson, B. A., Alekseyev, V. Y., Barton, J. K. (1999). A versatile mismatch 
recognition agent: specific cleavage of a plasmid DNA at a single base mispair. 
Biochemistry 38, 4655-4662.
20. Pyle, A. M., Long, E. C., Barton, J. K. (1989). Shape-selective targeting of DNA 
by (phenanthrenequinone diimine)rhodium(III) photocleaving agents. J. Am. 
94
Chem. Soc. 111, 4520-4522.
21. Gotoh, O., Wada, A., Yabuki, S. (1979). Salt-concentration dependence of melting 
profiles of lambda phage DNAs: Evidence for long-range interactions and 
pronounced end effects. Biopolymers 18, 805-824.
22. Baena, A., Leung, J. Y., Sullivan, A. D., Landires, I., Vasquez-Luna, N., 
Quinones-Berrocal, J., Fraser, P. A., Uko, G. P., Delgado, J. C., Clavijo, O. P., 
Thim, S., Meshnick, S. R., Nyirenda, T., Yunis, E. J., Goldfeld, A. E. (2002). 
TNF-alpha promoter single nucleotide polymorphisms are markers of human 
ancestry. Genes Immun. 3, 482-487.
95
Chapter 4:  Phosphatase Assisted DNA Modification
4.1:  Introduction
 In order to observe reactions of rhodium intercalators with DNA, a label must be 
incorporated into the DNA.  This label can be either radioactive or fluorescent.  Typically 
these are incorporated into DNA by an enzymatic method, although duplex DNA can be 
detected using fluorescent intercalators or groove binders without the need for modifying 
the DNA directly.  The 5’ terminus can be labeled with a radioactive phosphate by the 
kinase activity of T4 polynucleotide kinase, PNK.1  The 3’ end of DNA can be labeled 
either fluorescently or radioactively using terminal transferase.2; 3  As an alternative to 
end labeling of DNA, labeling the DNA at the site cleaved by rhodium intercalators was 
explored.  
 Rhodium intercalators abstract a hydrogen atom from a sugar ring of the DNA 
backbone at the intercalation site.4  Upon UV excitation, an electron is transferred from 
the intercalated ligand to the metal center, forming a ligand radical.5  this radical is 
capable of abstracting a hydrogen atom from the sugar ring, forming a radical which 
decomposes to yield a strand break.  Depending on which hydrogen is abstracted from the 
sugar ring different decomposition paths are possible.  In the case of [Rh(phen)2(phi)]Cl3, 
primarily the 3’ hydrogen is thought to be extracted.  Irrespective of the hydrogen atom 
abstracted, sugar radicals primarily decompose to a 3’-phosphate terminated DNA and a 
5’-phosphate terminated DNA with a base and sugar fragment missing.  Other complexes 
are believed to react via a similar hydrogen atom abstraction mechanism, although the 
hydrogen removed may vary.  
 Rhodium complexes are not unique in their production of 3’-phosphate terminated 
DNA.  3’-phosphate lesions are formed from a variety of other damage events.  DNA 
damage stemming from hydrogen atom abstraction at any sugar position results, at 
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least partially, in 3’-phosphate termini.6  Typical sources of hydrogen atom abstraction 
are reactive oxygen species such as hydroxyl radical or metal bound reactive oxygens 
such as copper or manganese oxo complexes, x-rays and gamma rays, ene-diyne drugs 
and photoactivated rhodium intercalator complexes.  Additionally, 3’-phosphate lesions 
are produced in the course of hydrolysis of DNA bases damaged by oxidation.7  If 
DNA bases become oxidized and are treated with a strong base such as piperidine, this 
results in hydrolysis and β elimination which will produce a strand break with both a 
3’-phosphate and 5’-phosphate termini.  In vivo, enzymatic repair also results in 3’-
phosphate termini.8
 These 3’-phosphate lesions are problematic because they are not substrates for 
the wide variety of DNA modifying enzymes.  In order to modify this terminus we must 
first remove the 3’-phosphate blocking lesion.  This repair is suspected to occur in vivo 
by either the apurinic endonuclease, APE1,9 or polynucleotide kinase 3’-phosphatase, 
PNKP.8; 10  PNKP is thought to be involved with the repair of single and double strand 
breaks formed by hydrogen atom abstraction, primarily high energy radiation such 
as x-rays or gamma rays.11  Since these enzymes are not commonly available, the 
more common T4-PNK enzyme has been used in these experiments.12  T4-PNK is a 
bacteriophage enzyme which catalyzes the same reactions as PNKP of higher organisms.  
Bacteria which T4 phage infect attempt to sabotage the T4 replication by expressing an 
endonuclease capable creating of 3’-phosphate termini.
4.2:  Experimental
 Materials.  Primers and oligonucleotides were synthesized on an ABI 394 DNA 
synthesizer using standard phosphoramidite chemistry.  The DNA was purified using 
PolyPakII cartridges.  Human genomic DNA, FastStart polyermase, calf intestinal 
phosphatase, shrimp alkaline phosphatase, were purchased from Roche.  Rhodium 
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complexes were synthesized as previously described.  ExoI, terminal transferase, and T4-
PNK were purchased from New England Biolabs.  Remaining chemicals were purchased 
from Sigma.
 Demonstration of T4-PNK repair.  1 μM of rac-[Rh(bpy)2(chrysi)]
3+ was added 
to 1 μM of 32P labeled mismatched DNA duplex template,  5’-32pi-TTA GGA TCA TCc 
ATA TA-3’ and 5’-TAT ATG CAT GAT CCT AA-3’ dissolved in 50 mM NaCl with 
10 mM sodium phosphate buffer pH 7.1.  This mixture was irradiated for 15 minutes 
using a solar simulator.  T4-PNK repair was performed by adding 3 μL of 10x PNK 
buffer (700 mM Tris-HCl, 100 mM MgCl2, 5 mM DTT pH 7.6), 6 μL water, and 10 U T4-
PNK.  This mixture was incubated for 1 hour and the reaction stopped by heating to 90ºC 
for 15 minutes.  The DNA samples were run on a denaturing polyacrylamide gel and 
imaged using phosphorimagery.  
 Fluorescent labeling of the cleaved site in a duplex.  A pooled human genomic 
DNA sample was amplified using primers specific for the TNF promoter region, F:AGA  
GAT AGA ACA AAA GGA TAA GGG CTC AG  and R:GTG TGG CCA TAT CTT 
CTT AAA CG using Roche FastStart High Fidelity polymerase according to standard 
proceedure.  After polymerization, 20 U calf intestinal alkaline phosphatase and 6 U 
exonuclease I were added.  The DNA was further purified by using a QIAgen PCR 
cleanup column and eluting in 10 mM Tris pH 8.0.  This DNA was denatured, by heating 
to 99ºC for 20 minutes and annealed, by the addition of buffer and slow cooling to room 
temperature, to generate a final concentration of 20 mM Tris pH 7.0 and 100 mM NaCl; 
this denaturation and annealing generates mismatches.  These mismatches were cleaved 
by 1 µM [Rh(bpy)2(chrysi)]3+ upon irradiation at 440 nm for 25 minutes.  After cleavage, 
80 U T4 polynucleotide kinase and 4 uL T4 ligase buffer were added to remove terminal 
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3’-phosphates.  This mixture was then dried under reduced pressure and labeled using 
Applied Biosystems’s SNaPshot kit following its procedures.  The fluorescently labeled 
products were separated and detected using an ABI 310 prism capillary electrophoresis 
instrument.  
 Protocol used in testing phosphatase assisted trasferase tagging PCR(PATT-
PCR).  DNA was PCR amplified from two plasmids which were polymorphic at a single 
site, one containing the G allele, the other contained the C allele with F: CGC GTT 
GGC CGA TTA ATT AAT G and R: GCT GCG CAA CTG TTG GGA AG  using Taq 
polymerase from Roche Biochemicals under standard conditions.  After polymerization, 
20 U calf intestinal alkaline phosphatase and 6 U exonuclease I were added.  The DNA 
was further purified by using a QIAgen PCR cleanup column and eluting in 10 mM 
Tris pH 8.0.  This DNA was denatured, by heating to 99ºC for 20 minutes and annealed, 
by the addition of buffer and slow cooling to room temperature, to generate a final 
concentration of 20 mM Tris pH 7.0 and 100 mM NaCl; this denaturation and annealing 
generates mismatches.  These mismatches were cleaved by 1 µM [Rh(bpy)2(chrysi)]3+ 
upon irradiation at 440 nm for 25 minutes.  After cleavage 80 U T4 polynucleotide kinase 
and 4 uL T4 ligase buffer were added to remove terminal 3’-phosphates.  The DNA was 
ethanol precipitated and dried under reduced pressure to remove the T4 ligase buffer.  The 
nicks in the DNA were tagged using terminal transferase under the following conditions: 
400 U recombinant terminal transferase, 200 mM potassium cacodylate, 25 mM Tris 
HCl, 5 μg BSA, 0.75 mM CoCl2, 5 μM dGTP in a total volume of 20 uL pH 6.6.  The 
reaction mixture was incubated at 37C for 1 hour and stopped by denaturing at 70ºC for 
20 minutes.  The tagged products were then amplified by Taq polymerase in two reactions 
under standard conditions, except with an annealing temperature of 45ºC using the 
primers F, as described above, F and C15 or R and c15.  The products of this reaction were 
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then analyzed by agarose gel electrophoresis.  
4.3:  Repair of 3’-phosphate termini using T4-PNK
 While the mechanism of cleavage has only been studied for a few rhodium 
complexes, the previous work with other intercalators has shown that 3’-phosphate 
termini occur in most hydrogen atom abstraction reactions.4  Because the chrysi and 
phzi intercalating ligands have not been structurally characterized with DNA, we cannot 
predict which hydrogen will be abstracted.  It could be possible that a different hydrogen 
atom would be extracted and hence different products could form. Despite this, most 
abstractions will result in 3’-phosphate termini to some extent.6  Initially, validation of the 
3’-phosphate terminus and repair using T4-PNK was sought.  
 A photocleavage reaction was performed with 1 μM [Rh(bpy)2(chrysi)]Cl3 
with 1 μM C-C mismatched DNA, shown in figure 4.1.  Products from photocleavage 
reactions were compared by denaturing gel electrophoresis and determined to have 
identical electrophoretic mobility as the Maxam-Gilbert reactions.  Maxam-Gilbert 
reactions produce only 3’-phosphate termini upon reaction with piperidine.  This suggests 
that 3’-phosphates are the major product in these reactions.
 Subsequently, mass spectra of the products from the cleavage reactions were 
obtained by Jens Brunner confirming these observations as being bona fide 3’-phosphates. 
Shortly after photocleavage some metastable intermediates are formed, but after many 
hours these decompose to 3’-phosphate termini.  It seems likely from these data that 
the hydrogen atom abstractions by chrysi and phzi complexes are the same, while the 
reaction using the phi ligand is distinct.
 Following the confirmation of 3’-phosphate terminated DNA, enzymatic 
hydrolysis of the phosphate was attempted using T4-PNK.  This reaction was found to 
proceed rapidly producing a slower migrating band which would be expected from the 
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Figure 4.1:  Demonstration of T4-PNK repair.  An oligonucleotide duplex 
containing a C-C mismatch, DC, is cleaved with Rhchrysi.  The cleaved band 
comigrates with the band in the AG Maxam-Gilbert reaction, indicating the 
presence of a 3’-phosphate.  This can be removed to form a slower migrating 
band with T4-PNK.
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decreased charge of the fragment.  Using this reaction, it should be possible to repair the 
DNA at the cleavage site to make it a substrate for further enzymatic reaction
4.4:  Utilizing 3’-phosphate repair for a new method of labeling DNA fragments
 Using T4-PNK we are able to repair 3’-phosphate lesions to produce a 
3’-hydroxyl end to the DNA.  Once this repair is complete, we can use the many 
other enzymes, such as DNA polymerases, DNA ligases, and terminal transferase, to 
functionalize the DNA.  In essence, we can now mark the site of damage within the 
DNA.  
 The initial application of this new method was the introduction of a fluorescent 
label at the site of damage.  This allows a significant simplification of the procedure 
for the discovery of SNPs.  The scheme outlined in figure 4.2 shows how this method 
would function in practice.  The DNA template would be created in a similar manner, but 
utilizing standard primers rather than restriction tagged primers.  The DNA would then be 
denatured and annealed to produce mismatches at the sites of SNPs.  Mismatch specific 
rhodium complexes would be added and irradiated.  The 3’-phosphate terminated DNA 
strand is repaired by T4-PNK and finally labeled using the SNaPshot kit.
 In practice, this method does work although only modestly.  This method was 
used to detect a single low frequency SNP within the TNF gene.  Under these conditions 
a new peak was detected 275 bases in length corresponding to the known SNP site in this 
sequence, as shown in figure 4.3.  A standard restriction site labeled analysis is shown 
for comparison.  The opposite side of the fragment is analyzed under these conditions so 
the peak sizes are necessarily different.  Without the irradition of rhodium complex or 
without addition of PNK, no cleaved product is observed.
 However, this method is not without its problems.  Rhodium complexes cause 
the base 3’ to the mismatched base to be eliminated, as illustrated in figure 4.4.  After 
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Figure 4.2:  The incorporation of a fluorescent tag at the cleavage site.  After 
oxidative cleavage of a site within the DNA, a 3’-phosphate remains.  This phosphate 
can be removed with T4-PNK.  After this the DNA becomes a substrate for labeling by 
polymerase or terminal transferase
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Figure 4.3:  Fluorescent labeling at a [Rh(bpy)2(chrysi)]
3+ cleavage site.  A.  
A cleaved mismatch, 101 bp, is visualized by labeling at the 3’ end of the DNA, 
shown for comparison.  B.  A label was introduced into the DNA at the cleavage 
site, 281 bp, after 3’-phosphate removal.  No label incorporation is seen without 
photocleavage or phosphate removal.
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Figure 4.4:  Poor labeling efficiency when labeling at the Rhchrysi cleavage site. 
When Rhchrysi cleaves a mismatch site, the base on the 3’ side of the mismatch 
is actually removed.  This leaves the mismatched base within the DNA.  When 
polymerase is used to incorporate a fluorescent base, it must extend a terminally 
mismatched primer.  
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repair, this will leave the mismatched base as the 3’-hydroxyl terminus of the DNA.  If 
we consider this situation was a primer and template in normal PCR, we have produced a 
mismatched primer and the biggest problem is that the mismatch corresponds to the last 
base of the primer.  It is interesting that we see any extension of the mismatched base, but 
this non-ideal situation results in a 60-fold reduction in labeling efficiency.  It is possible 
that if the T4-PNK were replaced by another enzyme, this problem could be bypassed.  
For example, APE1 catalyses the removal of 3’-phosphate termini by the hydrolysis 
of the 3’ nucleotide and the phosphate.  In this method, the mismatched base would be 
removed alleviating the problem.
4.5:  Phosphatase assisted transferase tagging
 The study of damaged sites in genomic DNA is a difficult subject.  While it is 
possible to look for damaged DNA bases by HPLC methods, there are relatively few 
methods for localizing damaged sites within genomic DNA.  Two methods currently exist 
which are capable of analyzing DNA damage on single nucleotide level.  The first method 
is ligation mediated PCR, LM-PCR.13  In LM-PCR, DNA is cleaved by some agent or 
DNA lesions are converted to strand breaks by piperidine or enzymatic treatment.14; 15  a 
single primer is added which is specific for a single site in the genome of interest.  This 
primer is bound and extended by polymerase to form a blunt end to the DNA.  This is 
followed by a ligation of a known sequence to the blunt end of the DNA molecule and 
amplification of the DNA by PCR.  This sounds simple and elegant, but in practice this 
method is difficult.  The problem is typically in the blunt end ligation, which has a poor 
efficiency.
 A more recent method is the terminal transferase dependent PCR.16  in this 
method, primer extension is performed several times to produce some single stranded 
DNA.  This extension depends on the ability of the polymerase chosen to occasionally 
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Figure 4.6:  Phosphatase assisted transferase tagging PCR (PATT-PCR).  
Oxidatively cleaved DNA contains a 3’-phosphate terminus.  This can be cleaved 
by T4-PNK to give an enzymatically active 3’-hydroxyl.  A homopolymer tail can 
then be incorporated at the cleavage site, marking it.  A primer complementary to 
the homopolymer tail and another primer can be used to observe the cleavage site 
by PCR.
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stop or occasionally bypass any damaged sites in the DNA, without the addition of 
repair enzymes.  The singled stranded DNA is then tailed with terminal transferase using 
ribonucleotides.  These ribonucleotides are poor substrates for terminal transferase which 
can typically only incorporate a few, typically 3, bases.  These 3 bases are annealed to 
a known DNA duplex with a complementary C tailed overhang.  This then forms the 
primed complex for amplification.  This method while an improvement over the LM-PCR 
method still suffers from some problems.  The main issue is the polymerase pausing at 
damaged sites.  Because polymerases vary in pausing at damaged sites, different results 
may be seen.  Regardless of the type of DNA damage, oxidation, reduction, adduct or 
protein crosslink, these pauses may occur resulting in ambiguous data.
 Using T4-PNK repair provides another possible route to localizing DNA 
damage, as shown in figure 4.6.  DNA can be damaged in vivo through a variety of 
different established methods such as dimethylsulfate13 or oxidative stress.15  the 
DNA can be extracted from the cells using by lysis and purified from the other cellular 
components through established methods.  The genomic DNA can then be digested 
with repair enzymes or treated simply with piperidine.  Using terminal transferase, a 
polynucleotide tail comprised of a single DNA base can be incorporated at the newly 
repaired 3’-hydroxyl terminated DNA break, effectively labels the site.  Then by 
performing PCR the product length will correspond to the damaged site.  This method 
has several advantages over the previously described methods in that it does not involve 
an unpredictable primer extension step or a blunt end ligation.  Additionally, this method 
allows for the observation of the 5’ side of the break, while the other methods both 
analyze the 3’ side.  
 In practice, this method has a complication.  Terminal transferase will 
append a homopolymer tail without difficulty; however, the length of the tail will be 
heterogeneous.  This problem is solved by the PCR amplification.  Since we choose 
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a specific primer length, say 15 base pairs, the primer can bind anywhere within 
the homopolymer tail.  For every amplification step, some of the homopolymer tail 
is lost until the substrate and primer lengths become equal. The lengthening of the 
homopolymer tail is not expected, as we can select a length and therefore annealing 
temperature at which primer binding will be permissible.  Lengthening could only occur 
under conditions where fewer bases would be annealed and therefore the process would 
be less favorable than the desired annealing.
 This method has been demonstrated in a model system.  A PCR product of the 
TNF promoter region was prepared.  This promoter region contains an SNP at a particular 
site which can be converted into a mismatch through denaturing and annealing.  This 
mismatch can be cleaved by [Rh(bpy)2(chrysi)]Cl3 introducing a single strand oxidative 
nick at a known location within the DNA duplex.  This oxidative nick contains a 
3’-phosphate terminus which can be repaired by T4-PNK.  Terminal transferase can then 
be used to attach a homopolymer tail at this site.  Because a short DNA duplex was used 
rather than genomic DNA, there are two additional 3’ termini which will also be tailed 
at the end of the duplex.  PCR can then be used to detect the products from either the 
forward primer site or the reverse site.  
 An example of this procedure is shown in figure 4.7.  In this experiment the 
DNA duplex was tagged with terminal transferase using different nucleotides.  There 
is a definite new product ~280 bp in length when the forward primer is used.  This 
seems to correspond with the position of the SNP plus the additional 15 bases from the 
homopolymer tail.  Using the reverse primer, little cleavage is observed as would be 
expected.  Using higher resolution capillary electrophoresis analysis, the new peak is 
274 bases in length which corresponds exactly with the SNP site, shown in figure 4.8.  
The full length product can also be seen at 440 bases.
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Figure 4.7:  PATT-PCR by agarose gel.  A SNP within the TNF promoter was 
cleaved by a mismatch specific complex as described within the text.  PATT-PCR 
was performed using all possible homopolymer tails, poly G tailing being the 
obvious best.  There a new band is clearly visible at ~300 base pairs in the forward 
primer reactions.
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Figure 4.8:  Analysis of a PATT-PCR reaction by capillary electrophoresis.  an 
identical reaction to that performed in figure 4.7 is shown here using capillary 
electrophoresis.  The new band is 274 bases in length which exactly corresponds to the 
SNP site in the TNF gene.  The peak at 440 bases corresponds to the PCR template used 
in the reaction.  Peaks below 100 bases are from incomplete extension.
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Chapter 5:  Mismatches in Genomic DNA
5.1:  Introduction to mismatch repair and genomic mismatches
 Cells are equipped with DNA repair machinery that systematically repairs various 
lesions within DNA.  Mismatch repair, MMR, is responsible for the detection and 
repair of base pair mismatches within the genome.1  These proteins are essential for the 
maintenance of genomic DNA and if the MMR system is disrupted through mutation2; 3 or 
epigenetic silencing4 the mutation rate within the cell increases dramatically.
 The human mismatch repair machinery is composed of several key proteins.1  
First, DNA mismatches are detected by a MutS homolog, either MutSα or MutSβ, 
composed of MSH2 and MSH6 or MSH2 and MSH3, respectively.  The two forms of 
MutS have somewhat different recognition properties, MutSα is believed to target mainly 
mismatches while MutSβ is believed to target primarily insertion deletion loops.  After 
recognition of a mismatch by MutS, a MutL homolog binds to MutS are coordinates the 
repair.  At least two forms of MutL are present in humans, MutLα and MutLβ, formed 
from MLH1 and either PMS2 or PMS1.  MLH1 has been shown to form heterodimers 
with other proteins as well.  The function of these various forms of MutL is not well 
understood.
 Because MSH2 or MLH1 are involved in all mismatch repair, their loss is 
detrimental to the entire process of mismatch repair.5  In vivo, mutations in these genes 
can cause both an increase in mutation rate, the mutator phenotype,2 and instability of 
short repeats of DNA, microsatellite instability.6  These two types of genetic instability 
within humans are responsible for hereditary non-polyposis colon cancer or HNPCC.7  
Additionally, 18% of all solid tumors8 and a significant number of leukemias9 also are 
mismatch repair deficient.  The loss of the other mismatch repair proteins can also cause 
increases in certain types of genetic instability which may also lead to cancer.10
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 In addition to being a predisposing factor for cancer, loss of mismatch repair also 
confers resistance to many common chemotherapeutics.11  Mismatch repair deficient 
tumors have been reported to be resistant to alkylating agents12, platinum drugs13 and 
metabolic analogs14.  It is believed that the mismatch repair proteins are involved to some 
extent with the recognition of these lesions.  The recognition of these lesions then would 
normally cause the induction of apoptosis.15
 Typically, the way in which mismatch repair deficiency is assessed is by 
investigating several microsatellite regions in the genome.16  These are amplified by 
PCR and length of the microsatellite is investigated by gel electrophoresis.  Additionally, 
immunological methods for the detection of MSH2 or MLH1 are sometimes also 
employed.  Depending of the microsatellites selected for assay, different outcomes can be 
obtained.17  
 Within our group we have developed bulky rhodium metallointercalators 
which can bind mismatches in DNA, shown in figure 5.1.  These compounds bind 
mismatches by intercalation and upon UV photoexcitation can cleave the DNA at the 
mismatch site.18; 19  Our first generation complex [Rh(bpy)2(chrysi)]Cl3, Rhchrysi, can 
bind mismatches with moderate affinity and high specificity.18  The high specificity of 
Rhchrysi is beautifully demonstrated in its ability to cleave a single mismatched site in 
a 2700 base pair duplex.20  The second generation complex [Rh(bpy)2(phzi)]Cl3, Rhphzi, 
utilized heterocyclic nitrogens to boost the affinity of the complex.19  Rhphzi is capable of 
binding mismatched sites with 100 nM affinity and similar specificity to Rhchrysi.  Using 
these complexes, a method for the detection of mismatched DNA bases in genomic DNA 
has been developed.
 Previously, a method for the detection of mismatches within genomic DNA was 
developed using these mismatch specific rhodium complexes.19  In this method, genomic 
























Figure 5.1:  Structures of Rhchrysi and Rhphzi.  Rhchrysi is our first generation 
mismatch binding molecule.  It is capable of binding to 80% of the possible 
mismatches with moderate affinity.  Rhphzi is a higher affinity complex which has 
similar recognition properties to Rhchrysi.
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pieces with an average length of 4 kb.  These fragments were then labeled with 32P-
phosphate using T4-PNK. This genomic DNA was then cleaved by either Rhchrysi or 
Rhphzi and light.  The fragments were then separated using an alkaline agarose gel and 
visualized with phosphorimagery.  The change in the fragment distribution was then used 
to quantify the degree to which mismatches were contained within the genomic DNA.
 This method while effective is difficult in both performance and analysis.  A 
simpler scheme was envisioned wherein a radioactive phosphate or fluorescent tag would 
be installed at the cleavage site.  This would provide a method for a new straightforward 
analysis of mismatches within genomic DNA.  This method may prove to be an 
invaluable tool in the early detection of HNPCC and other MMR deficient cancers as 
mismatched bases occur with higher frequency than insertion/deletion loops.
5.2:  Experimental
 Cell lines, Media and Culture.  The DU145 and SW620 cell lines were obtained 
from the ATCC.  Cells were grown in Leibovitz L-15 for SW620 or Minimum Essential 
Media (MEM) alpha modification for DU145, supplemented with 10% fetal bovine 
serum, 100 U/mL penicillin, 100 ug/mL streptomycin.  Cells were grown in Corning 
Costar tissue culture flasks and dishes at 37°C under 5% CO2 atmosphere.
 Isolation of DNA.  DNA was isolated from cultured cells using the QIAgen 
DNeasy kit and protocol.  The DNA was quantitated by UV spectroscopy and diluted to 
100 μM DNA bases.
 Labeling at mismatched sites.  Isolated cellular DNA is placed into a solution 
with 500 nM Rhchrysi, 50 mM NaCl, and 10 mM Tris pH 7.0 in a final reaction volume 
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Figure 5.1:  Detection of mismatches in genomic DNA.  Genomic DNA is 
extracted from cells grown in cell culture.  The genomic DNA is mixed with the 
mismatch specific metal complex Rhchrysi which cleaves DNA at mismatched 
sites with UV irradiation.  Radioactivity is incorporated at the cleaved sites 
using terminal transferse.  The radioactivity is then quantitated by scintillation 
counting.
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of 20 uL.  These are irradiated with a solar simulator, UVB/UVC filtered, for 15 minutes.  
To the 20 uL reaction, 5 uL of 5x of a special PNK buffer is added which contains 50 mM 
MgOAc, 100 mM Tris OAc pH 7.9, 5 mM DTT, and 5 mM ATP.  To this 10 U, in 1 uL, 
of PNK is added and allowed to react 1 hour at 37 ºC.  After this point 10 U, in 1 uL, of 
SAP are added to destroy the ATP in the PNK buffer.  This is allowed to react for 1 hour 
followed by inactivation of PNK and SAP at 75 ºC for 15 minutes.  After this the reaction 
mixture is adjusted for the terminal transferase reaction by the addition of 3 uL of a 10x 
terminal transferase additive buffer which contains 500 mM KOAc and 2.5 mM CoCl2.  
Along with this 20 U, in 1 uL, of terminal transferase and 1 uL of α32P-ddATP are added.  
Following this reaction, 10 U of SAP are again added to convert the 32P into inorganic 
phosphate which is more easily removed.
 
 Quantification of 32P incorporated into DNA.  Radioactive phosphate 
incorporation was analyzed by the acid precipitation of DNA onto filter paper.21  
Approximately 1 cm2 pieces of filter paper are cut and spotted with 10 uL of the reaction 
mixtures.  The paper are numbered with indelible marks, either graphite pencil or laser 
printed numbers, and placed into a 5% trichloroacetic acid, TCA,  solution to precipitate 
onto the filter paper in a batch precipitation process in an Erlenmeyer flask.  Squares 
without applied radioactivity are used as a control the acid precipitation process.  The 
unreacted ATP which was converted to inorganic phosphate dissolves easily in the acid 
solution.  This is rinsed 3x with the TCA solution then dehydrated with absolute ethanol.  
As the solution drains from the flask radioactivity is monitored by Geiger counter.  If 
significant radioactivity remains in solution after the third rinse with TCA, more rinses 
may be performed.  The filter paper is then allowed to dry and precipitated radioactivity 
is quantitated by dry scintillation by Cherenkov quenching.
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5.3:  Quantification of mismatches in genomic DNA using terminal transferase
 As an alternative to the alkaline agarose gel method, a new method was 
developed.  Instead of looking at the shifts of labeled pieces of DNA, DNA is 
labeled with radioactivity at the sites were cleavage occurs.  This provides a move 
straightforward method for the detection of mismatched sites within the DNA.
 Genomic DNA is isolated from cells grown in culture.  This genomic DNA 
is then cleaved using a mismatch specific complex such as Rhchrysi.  Because of the 
mechanism of cleavage, the cleaved site will have a 3’-phosphate which is enzymatically 
inactive.  The 3’-phosphate is removed using T4-PNK.  After removal, the nick can 
be radioactively labeled using terminal transferase and α32P-ddATP.  The DNA is 
precipitated onto a small piece of filter paper and quantitated by scintillation counting.
 Two different cell lines were grown to produce genomic DNA.  The SW620 
cell line is an epithelial cell line from colorectral adenocarcinoma.22  this cell line is 
mismatch repair-proficient and has been shown to have normal to high amounts of the 
key MSH2 and MLH1 proteins.23  The other cell line is DU145 which is an epithelial 
cell line from a prostate carcinoma.24  This cell line is mismatch repair-deficient and has 
no MLH1 and low MSH2.25  These two cell lines were used for testing of this method of 
detecting mismatches in genomic DNA.
 This method was first tested using the nonspecific DNA intercalator 
[Rh(bpy)2(phi)]
3+.  This complex should bind equally well to genomic DNA with 
or without DNA mismatches and should consequently shown similar amounts of 
32P incorporation.  Experiments using this complex were conducted at a range of 
concentrations which correspond to 1/10000 base pairs, 1/1000 base pairs, 1/100 base 
pairs or 1/10 base pairs.  As can be seen from figure 5.2, both DU145 and SW620 show 
similar levels of radioactive incorporation as should be expected.  When large amounts of 
rhodium complex are used, the amount of radioactivity incorporated decreases.  This is 
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Figure 5.2:  Incorporation of radioactivity after photocleavage using the 
nonspecific Rhphi complex.  If a nonspecific DNA cleavage agent is used similar 
amounts of radioactivity are incorporated into the genomic DNA of both DU145 and 
SW620.  Genomic DNA was extracted from the cell lines.  The DNA was dissolved in 
50mM NaCl, 10mM Tris pH 7.0.  DNA concentrations were adjusted to 300mM bases. 
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likely because the genomic DNA is extremely damaged and cleaved to small fragments.  
This has been shown to decrease the efficiency of nucleotide incorporation by terminal 
transferase.26
 When genomic DNA was cleaved by the mismatch-specific complex 
[Rh(bpy)2(chrysi)]
3+, radioactivity is only incorporated into the genomic DNA of 
the DU145 mismatch repair deficient cell line, as shown in figure 5.3.  The amount 
of radioactivity increases with increasing amounts of [Rh(bpy)2(chrysi)]
3+.  At the 
same time the genomic DNA of SW620 does not show any increase in radioactivity 
incorporation with [Rh(bpy)2(chrysi)]
3+ of any concentration.  This is surprising as at high 
concentrations of rhodium complex, some nonspecific binding would be expected based 
purely upon the nonspecific binding constant.  This should cause some cleavage and 
labeling of the SW620 cell line.  However, binding and photocleavage efficiency are not 
one in the same.  Upon photoexcitation of rhodium complexes a short lived ligand radical 
forms which is capable of hydrogen atom abstraction.27  If this radical is not positioned 
correctly, as is likely the case with nonspecific binding, hydrogen atom abstraction does 
not occur as readily as in the case of mismatch binding.
 If the amounts of radioactivity are compared between [Rh(bpy)2(chrysi)]
3+ and 
[Rh(bpy)2(phi)]
3+ cleavage experiments, the number of [Rh(bpy)2(chrysi)]
3+ binding sites 
per base pair of genomic DNA can be estimated.  In this case, the data suggest that 1 base 
in 3000 base pairs forms a site for [Rh(bpy)2(chrysi)]
3+ binding.  
 The amount of radioactivity incorporated by this method will be proportional to 
the number of breaks within the DNA from all sources.  The genomic DNA is sheared 
to some extent by its isolation.  As no precautions are taken to reduce shearing, typically 
the DNA is fragmented into 50–100 kb pieces.  If cells are experiencing either necrosis 
or apoptosis, the genomic DNA may be extremely fragmented which will skew the data 
substantially.
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Figure 5.3:  Radioactivity incorporated using the mismatch specific complex 
Rhchrysi.  Increasing amounts of radioactivity are into the genomic DNA from the 
mismatch repair deficient DU145 cell line, with increasing amounts of Rhchrysi.  
Under the same conditions essentially no radioactivity above background is 
incorporated into the genomic DNA of the mismatch repair proficient SW620 cells.  
The DNA was dissolved in 50 mM NaCl, 10 mM Tris pH 7.0.  The concentration of 
DNA was adjusted to 300 mM bases. The concentration of Rhchrysi is as indicated.  
Samples were irradiated for 15 minutes and labeled according to the experimental 
proceedure.
123
 These data is in direct conflict with previously measured mutation rates in 
mismatch repair deficient cell lines which place mutation rates at ~1 in 106/base/
generation.2; 28  These experiments used loss of function methodology where hprt, 
necessary for 6-thioguanine to be toxic, must become mutated in order for the cell to 
survive.  Since hprt is located on the X chromosome there is only one copy of the gene 
which must become mutated.  These experiments are generally neutral to the type of 
mutation, transition, transversion or frameshift, but only mutations at particular sites can 
produce a loss of function mutant.  Because only a small fracation of the bases within the 
gene are functionally assessed, one mutation does correspond to a single mismatch, but 
one mismatch may or may not correspond to a loss of function mutation.
 Recent data have suggested that much higher mutation rates may occur under 
non-ideal growth conditions.  One such non-ideal condition is oxidative stress.  Mismatch 
repair deficient cell lines have been shown to have greatly enhanced mutation rates under 
oxidative conditions, presumably because mismatch repair does repair some oxidized 
lesions.29; 30  These mutation rates only tell us about the number of unrepaired mutagenic 
lesions within the genomic DNA after a whole cell cycle worth of DNA repair.  It seems 
reasonable based upon the efficiency of base excision repair of oxidized lesions within 
DNA that the number of lesions may be greater by an order of magnitude or possibly 
more than the mutation rate.  
 The DU145 cell line is considered incompetent for mismatch repair because of 
the complete lack of the MLH1 protein.  Despite this cellular extracts from DU145 are 
able to repair a variety of mismatches in an in vitro repair assay.25  Other mismatch repair 
deficient cell lines have also shown this depressed mismatch repair activity.2; 6  these 
observations suggest that perhaps they are not completely mismatch repair deficient but 
rather mismatch repair compromised.  Perhaps higher levels of mismatches occur than the 
mutation rate alone indicates.  No direct measurements of mismatches in genomic DNA 
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have been made previously so perhaps there are more than we have previously expected.
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Chapter 6:  Hypersensitivity of Mismatch Repair Deficient 
Cells to Bulky Rhodium(III) Intercalators
6.1:  Introduction
 DNA repair is essential for maintenance of genomic integrity.  Mismatch repair, 
MMR, is responsible for the recognition and repair of mispaired DNA bases, small 
insertion or deletion loops and some chemically damaged bases.1; 2  With a deficiency in 
MMR, the mutation rate in cells is enhanced3 and repetitious DNA sequences can become 
unstable.4
 MMR deficiency is an integral part of the formation of some cancers.  Loss of 
functional MLH1, MSH2, MSH3, MSH6, PMS1 or PMS2 cause MMR deficiency.5  
Those who have inherited a defective copy of any of these genes are especially at risk 
of developing certain endothelial cancers, primarily colon cancer.6  This syndrome is 
termed hereditary non-polyposis colon cancer, HNPCC.  In addition to this syndrome, 
approximately 18% solid tumors which are tested for mismatch repair are found to be 
deficient.7  While mismatch repair is not essential to cancer, it can greatly accelerate the 
rate at which other essential mutations are introduced.8; 9
 In addition to being a predisposing factor for the formation of tumors, mismatch 
repair deficiency is also associated with a tolerance of many common chemotherapeutics 
including alkylating agents, platinum compounds, topoisomerase inhibitors, and 
metabolic analogs.10  Mismatch repair deficient cell lines have been shown to be 
hypersensitive to certain drugs including topoisomerase inhibitors captothecin and 
etoposide11, DNA double strand break inducing bleomycin12, and methylating agent 
























Figure 6.1:  Structures of Rhchrysi and Rhphzi.  Rhchrysi is our first generation 
mismatch binding molecule.  It is capable of binding to 80% of the possible 
mismatches with moderate affinity.  Rhphzi is a higher affinity complex which has 
similar recognition properties to Rhchrysi.
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recurrent tumors which are drug resistant obtain this trait through MMR deficiency.14  
Because there are few compounds which are active against MMR deficient cells, new 
compounds are being sought which will be active against mismatch repair deficient 
tumors.
 Within our group we have developed bulky rhodium metallointercalators 
which can bind mismatches in DNA, shown in figure 6.1.15; 16  These compounds bind 
mismatches by intercalation and upon UV photoexcitation can cleave the DNA at the 
mismatch site.  Our first generation complex [Rh(bpy)2(chrysi)]Cl3, Rhchrysi, can bind 
mismatches with moderate affinity and high specificity.  The high specificity of Rhchrysi 
is beautifully demonstrated in its ability to cleave a single mismatched site in a 2700 
base pair duplex.17  The second generation complex [Rh(bpy)2(phzi)]Cl3, Rhphzi, utilized 
heterocyclic nitrogens to boost the affinity of the complex.16  Rhphzi is capable of binding 
mismatched sites with 100 nM affinity and similar specificity to Rhchrysi.  Here we 
report our initial in vivo experiments with Rhchrysi and Rhphzi in model mismatch repair 
deficient and proficient cell lines.
6.2:  Experimental
 Materials. Rac-[Rh(bpy)2(chrysi)]Cl3 and rac-[Rh(bpy)2(phzi)]Cl3 were 
synthesized using established procedures.15; 16  Rac-[Rh(bpy)2(chrysi)]Cl3 was resolved 
into Δ and Λ isomers using potassium antimonyl tartrate as previously described.18  Salts 
were exchanged to chloride before use using Sephadex QAE ion exchange resin.  Media 
and supplements were purchased from Invitrogen.  5-bromodeoxyuridine, antibodies, 
buffers and peroxidase substrate were purchased in kit format from Roche Molecular 
Biochemicals.  Irradiations were performed using a Oriel 1000 W Hg/Xe solar simulator 
using a UVB/C blocking filter.
 Cell lines, Media and Culture.  The HCT116N and HCT116O cell lines were 
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obtained from the National Cancer Institute (Bethesda, MD).19  Cells were grown in 
RPMI-1640 media supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 
0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 100 U/mL penicillin, 100 ug/
mL streptomycin, 400 ug/mL geneticin (G418).  Cells were grown in Corning Costar 
tissue culture flasks and dishes at 37 °C under 5% CO2 atmosphere.
 Cell proliferation assays.  Cell proliferation was measured using the 
5-bromouracil incorporation assay.20  Cells were plated in 96 well plates at 2000 cells/
well and grown for 24 hours.  At this point, various concentrations of rhodium complexes 
were added.  The cultures were cell cultures were allowed to grow for 48 hours or 
6–96 hours as indicated.  Cells were either irradiated or not followed by the addition of 
5-bromodeoxyuridine, BrdU.  Irradiation of cells were performed by a solar simulator 
adapted for irradiation from the bottom of the well plates.  The cells were grown for 
an additional 24 hours.  The BrdU incorporation was assayed by antibody assay using 
established procedures.
 Rhodium isomers photocleavage of mismatched DNA.  1 μM of either Δ or 
Λ [Rh(bpy)2(chrysi)]
3+ were added to 1 μM of 32P labeled mismatched DNA duplex 
template,  5’-32pi-TTA GGA TCA TCC ATA TA-3’ and 5’-TAT ATG CAT GAT CCT AA-
3’ dissolved in 50 mM NaCl with 10 mM sodium phosphate buffer pH 7.1.  This mixture 
was irradiated for 10 minutes using a solar simulator.  The irradiated DNA was run on a 
denaturing polyacrylamide gel and imaged using phosphorimagery.  
6.3:  Antiproliferative effects of rhodium compounds
 The cytotoxicity of our compounds was assessed in the HCT116 derived cell 
lines.  These cell lines have had an extra copy of either chromosome 2, HCT116O, or 
3, HCT116N, inserted in the cell.  Placing a copy of chromosome 3 within this cell line 
corrects the mismatch repair deficiency by replacing the MLH1 gene with a functional 
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Figure 6.2:  Differential antiproliferative effect of MNNG, Rhchrysi and 
Rhphzi on mismatch repair deficient and proficient cell lines. Mismatch repair 
deficient, O, and proficient, N, cell lines derived from the HCT116 cell line were 
treated with the methylating agent MNNG or Rhchrysi or Rhphzi.  As is typical the 
mismatch repair deficient population is resistant to the action of MNNG15, but is 
sensitive to Rhchrysi and Rhphzi.
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copy normal promoter. These cell lines give us a convenient method for testing whether 
or not a particular compound will differentially target mismatch repair deficient 
cells, since these cells are essentially genetically identical except for mismatch repair 
proficiency.  
 These HCT116 derived cell lines were treated with either Rhchrysi or Rhphzi for 
48 hours at varying concentrations.  The results are shown in figure 6.2.  For both of the 
tested compounds we see a significant inhibition of proliferation of the mismatch repair 
deficient strain.  This contrasts with the action of MNNG, a DNA methylating agent, 
which is more toxic to the mismatch repair proficient cell line.19  
 The effect of incubation time was also investigated, the results are shown in 
figure 6.3.  Cells were exposed to various concentrations of Rhchrysi for varying 
amounts of time from 6 to 96 hours.  In this series it is clear that maximum effect is 
obtained after 48 hours of incubation.
 Experiments were also conducted using enantiomerically pure Rhchrysi.  Shown 
in figure 6.5 is an example of the enatiospecific interaction of Rhchrysi with a C-C 
mismatch within an oligonucleotide.  Upon excitation of the complex with UV radiation, 
the complex cleaves the DNA at the site of intercalation.  For this particular sequence 
only the Δ isomer binds to the DNA.  In general, the Δ isomer binds to mismatched DNA 
more tightly than the Λ isomer.  
 The antiproliferative effects of these two isomers were also assessed.  Results of 
this experiment are shown in figure 6.4.  Clearly, the Δ isomer is the isomer responsible 
for the antiproliferative effect.  Since the opposite enantiomer is inactive, we suggest that 
the active compound is the intact rhodium complex, and no decomposition of the metal 
complex occurs intracellularly to form the active species.  These complexes are capable 
of cleaving DNA upon UV irradiation.15; 16  Some increase in toxicity is noted with 15 
minutes of irradiation and only for the Δ isomer.
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Figure 6.3:  Effect of varying drug incubation time on cell proliferation.  cells 
were exposed to varying concentrations of Rhchysi for different incubation times as 
shown.  Antiproliferative effects increased with longer incubation times upto 48 hours. 
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Figure 6.4:  Antiproliferative effect of different stereoisomers and irradiation of 
Rhchrysi.  The octahedral metal center of Rhchrysi and Rhphzi is chiral producing 
two different isomers.  These isomers can be separated and tested for antiproliferative 
effects individually.  As shown above the Δ isomer appears to be the only active 
compound.  This is significant as it shows that the compound is not dissociating 
within the cell.  These complexes are photoreactive with DNA in vitro, so the effect 
of irradiation was also explored.  As shown a small enhancement of antiproliferative 
effect is noted upon irradiation
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Figure 6.5:  Effect of stereoisomers on photocleavage.  A C-C mismatch is 
incorporated at the site indicated by the arrow on the right side.  Cleavage is 
only noted with Δ-Rhchrysi in the presence of a mismatch.  1, 11 are AG and 
2, 12 are CT Maxam-Gilbert reactions.  3 and 7 are light controls, without 
Rhchrysi. 4 and 8 are dark controls with rac-Rhchrysi. 5 and 9 are reactions 
using Δ-Rhchrysi.  6 and 10 are reactions with Λ-Rhchrysi.
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 MNNG is typical of most chemotherapeutics which target genomic DNA.  MMR 
deficient cell lines are resistant to the majority of alkylating drugs, platinum compounds 
and metabolic analogs.10  The cytotoxicity and antiproliferative effects these compounds 
have on cancerous cells are due in part to recognition of the drug induced genomic DNA 
damage by the mismatch repair system.21  This recognition causes cell cycle arrest and in 
some cases apoptosis.
 While these results are by no means conclusive, they are not inconsistent with 
genomic DNA being the target of these compounds.  These compounds do intercalate into 
dna in vitro at mismatched sites with high affinity and specificity.  While the mechanism 
of action is not clearly understood for these complexes, the ability of these complexes to 
inhibit growth of mismatch repair deficient cells is intriguing.
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